High-density electrode-based medical device system

ABSTRACT

A medical device system is disclosed including a high-density arrangement of transducers, which may be configured to ablate, stimulate, or sense characteristics of tissue inside a bodily cavity, such as an intra-cardiac cavity. High-density arrangements of transducers may be achieved, at least in part, by overlapping elongate members on which the transducers are located, and varying sizes, shapes, or both of the transducers, especially in view of the overlapping of the elongate members. Also, the high-density arrangements of transducers may be achieved, at least in part, by including one or more recessed portions in an elongate member in order to expose one or more transducers on an underlying elongate member in a region adjacent an elongate-member-overlap region.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No.13/793,213, filed Mar. 11, 2013, now U.S. Pat. No. 9,480,525, issuedNov. 1, 2016, which:

(a) is a continuation-in-part of prior International Application No.PCT/US2012/022061, which has an international filing date of Jan. 20,2012, and which claims the benefit of each of U.S. ProvisionalApplication No. 61/435,213, filed Jan. 21, 2011; U.S. ProvisionalApplication No. 61/485,987, filed May 13, 2011; U.S. ProvisionalApplication No. 61/488,639, filed May 20, 2011; and U.S. ProvisionalApplication No. 61/515,141, filed Aug. 4, 2011;

(b) is a continuation-in-part of prior International Application No.PCT/US2012/022062, which has an international filing date of Jan. 20,2012, and which claims the benefit of each of U.S. ProvisionalApplication No. 61/435,213, filed Jan. 21, 2011; U.S. ProvisionalApplication No. 61/485,987, filed May 13, 2011; U.S. ProvisionalApplication No. 61/488,639, filed May 20, 2011; and U.S. ProvisionalApplication No. 61/515,141, filed Aug. 4, 2011; and

(c) claims the benefit of each of U.S. Provisional Application No.61/649,734, filed May 21, 2012; U.S. Provisional Application No.61/670,881, filed Jul. 12, 2012; U.S. Provisional Application No.61/723,311, filed Nov. 6, 2012; and U.S. Provisional Application No.61/734,750, filed Dec. 7, 2012. The entire disclosure of each of theapplications cited in this Cross-Reference to Related ApplicationsSection is hereby incorporated herein by reference.

TECHNICAL FIELD

Aspects of this disclosure generally are related to a medical devicesystem including a high-density arrangement of transducers. In someembodiments, the transducers are configured to ablate or sensecharacteristics of tissue inside a bodily cavity.

BACKGROUND

Cardiac surgery was initially undertaken using highly invasive openprocedures. A sternotomy, which is a type of incision in the center ofthe chest that separates the sternum was typically employed to allowaccess to the heart. In the past several decades, more and more cardiacoperations are performed using intravascular or percutaneous techniques,where access to inner organs or other tissue is gained via a catheter.

Intravascular or percutaneous surgeries benefit patients by reducingsurgery risk, complications and recovery time. However, the use ofintravascular or percutaneous technologies also raises some particularchallenges. Medical devices used in intravascular or percutaneoussurgery need to be deployed via catheter systems which significantlyincrease the complexity of the device structure. As well, doctors do nothave direct visual contact with the medical devices once the devices arepositioned within the body.

One example of where intravascular or percutaneous medical techniqueshave been employed is in the treatment of a heart disorder called atrialfibrillation. Atrial fibrillation is a disorder in which spuriouselectrical signals cause an irregular heartbeat. Atrial fibrillation hasbeen treated with open heart methods using a technique known as the“Cox-Maze procedure”. During this procedure, physicians create specificpatterns of lesions in the left and right atria to block various pathstaken by the spurious electrical signals. Such lesions were originallycreated using incisions, but are now typically created by ablating thetissue with various techniques including radio-frequency (RF) energy,microwave energy, laser energy and cryogenic techniques. The procedureis performed with a high success rate under the direct vision that isprovided in open procedures, but is relatively complex to performintravascularly or percutaneously because of the difficulty in creatingthe lesions in the correct locations. Various problems, potentiallyleading to severe adverse results, may occur if the lesions are placedincorrectly. It is particularly important to know the position of thevarious transducers which will be creating the lesions relative tocardiac features such as the pulmonary veins and mitral valve. Thecontinuity, transmurality, and placement of the lesion patterns that areformed can impact the ability to block paths taken within the heart byspurious electrical signals. Other requirements for various ones of thetransducers to perform additional functions such as, but not limited to,mapping various anatomical features, mapping electrophysiologicalactivity, sensing tissue characteristics such as impedance andtemperature and tissue stimulation can also complicate the operation ofthe employed medical device.

However, conventional transducer-based intra-bodily-cavity devices haverelatively few transducers due to conventional technological limitationsand, consequently, have difficulty gathering adequate information andperforming proper lesion formation. Accordingly, a need in the artexists for improved intra-bodily-cavity transducer-based devices.

SUMMARY

At least the above-discussed need is addressed and technical solutionsare achieved by various embodiments of the present invention. In someembodiments, device systems exhibit enhanced capabilities for thedeployment and the activation of various transducers, which may belocated within a bodily cavity, such as an intra-cardiac cavity. In someembodiments, systems or a portion thereof may be percutaneously orintravascularly delivered to position the various transducers within thebodily cavity. Various ones of the transducers may be activated todistinguish tissue from blood and may be used to deliver positionalinformation of the device relative to various anatomical features in thebodily cavity, such as the pulmonary veins and mitral valve in anatrium. Various ones of the transducers may employ characteristics suchas blood flow detection, impedance change detection or deflection forcedetection to discriminate between blood and tissue. Various ones of thetransducers may be used to treat tissue within a bodily cavity.Treatment may include tissue ablation by way of non-limiting example.Various ones of the transducers may be used to stimulate tissue withinthe bodily cavity. Stimulation can include pacing by way of non-limitingexample. Other advantages will become apparent from the teaching hereinto those of skill in the art.

In some embodiments, a medical device system may be summarized asincluding a structure that includes a plurality of elongate members,each of the elongate members including a proximal end, a distal end, andan intermediate portion between the proximal and distal ends. Themedical device system further includes a plurality of electrodes locatedon the structure, the plurality of electrodes positionable in a bodilycavity. A first group of the electrodes is located on a first elongatemember of the plurality of elongate members and a second group of theelectrodes is located on a second elongate member of the plurality ofelongate members. The structure is selectively moveable between adelivery configuration in which the structure is sized to bepercutaneously delivered to the bodily cavity and a deployedconfiguration in which the structure is expanded to have a size toolarge to be percutaneously delivered to the bodily cavity. Theintermediate portions of the elongate members are angularly arrangedwith respect to one another about a first axis when the structure is inthe deployed configuration. Each electrode of the first group of theelectrodes is intersected by a first plane having no thickness and eachelectrode of the second group of the electrodes is intersected by asecond plane having no thickness when the structure is in the deployedconfiguration. The first and the second planes are non-parallel planesthat intersect each other along a second axis, and at least a firstelectrode of the plurality of electrodes is intersected by each of thefirst plane and the second plane when the structure is in the deployedconfiguration. The first electrode is not intersected by each of thefirst axis and the second axis when the structure is in the deployedconfiguration.

In some embodiments, the second axis is parallel to the first axis. Insome embodiments, the first axis and the second axis are collinear. Insome embodiments, the first axis intersects at least one other electrodeof the plurality of electrodes that does not include the first electrodewhen the structure is in the deployed configuration. In someembodiments, the second axis intersects at least one other electrode ofthe plurality of electrodes that does not include the first electrodewhen the structure is in the deployed configuration.

Each of the plurality of elongate members may include a curved portionhaving a curvature configured to cause the curved portion to extendalong at least a portion of a respective curved path, the curvatureconfigured to cause the curved path to intersect the first axis at eachof a respective at least two spaced apart locations along the first axiswhen the structure is in the deployed configuration. At least some ofthe plurality of electrodes may be radially spaced about the first axiswhen the structure is in the deployed configuration. At least some ofthe plurality of electrodes may be circumferentially arranged about thefirst axis when the structure is in the deployed configuration. Theintermediate portion of the first elongate member may overlap theintermediate portion of the second elongate member at a location on thestructure passed through by the first axis when the structure is in thedeployed configuration. The intermediate portion of the first elongatemember may overlap the intermediate portion of the second elongatemember at each of a first location on the structure passed through bythe first axis and a second location on the structure passed through bythe second axis when the structure is in the deployed configuration.Each of the plurality of elongate members may be arranged to be advanceddistal end-first into the bodily cavity when the structure is in thedelivery configuration. The intermediate portion of the first elongatemember may be adjacent the intermediate portion of the second elongatemember when the structure is in the deployed configuration.

In some embodiments, the first group of the electrodes may include apair of adjacent ones of the electrodes located on the first elongatemember. A region of space associated with a physical portion of thestructure may be located between the respective electrodes of the pairof adjacent ones of the electrodes located on the first elongate member,the region of space intersected by the first plane when the structure isin the deployed configuration. The respective electrodes of the firstgroup of the electrodes may be spaced along a length of a portion of thefirst elongate member, the length of the portion of the first elongatemember extending along the first elongate member between the proximaland the distal ends of the first elongate member. The entirety of thelength of the portion of the elongate member may be intersected by thefirst plane when the structure is in the deployed configuration. Thefirst group of the electrodes, the second group of the electrodes, oreach of both the first and the second groups of the electrodes mayinclude three or more of the plurality of electrodes.

In some embodiments, the first plane may intersect every electrode thatis located on the first elongate member when the structure is in thedeployed configuration. In some embodiments, the second plane mayintersect every electrode that is located on the second elongate memberwhen the structure is in the deployed configuration. In someembodiments, the first group of the electrodes includes the firstelectrode and the second group of the electrodes does not include thefirst electrode. At least some of the plurality of electrodes may bearranged in a plurality of concentric ringed arrangements when thestructure is in the deployed configuration, a first one of the pluralityof concentric ringed arrangements having a fewer number of theelectrodes than a second one of the plurality of concentric ringedarrangements. The first one of the plurality of concentric ringedarrangements may include the first electrode.

The first elongate member may include an edge interrupted by a notch,the notch located to expose at least a portion of at least a secondelectrode located on the second elongate member as viewed towards thesecond electrode along a direction parallel to a direction that thefirst axis extends along when the structure is in the deployedconfiguration. The second group of the electrodes may include the secondelectrode. The second electrode may be adjacent the first electrode whenthe structure is in the deployed configuration.

In some embodiments, the first elongate member may include a surfaceinterrupted by a channel, the channel located to expose at least aportion of at least a second electrode located on the second elongatemember as viewed towards the second electrode along a direction parallelto a direction that the first axis extends along when the structure isin the deployed configuration. In some embodiments, the first elongatemember may include a jogged portion, the jogged portion undergoing atleast one change in direction as the jogged portion extends between theproximal and the distal ends of the first elongate member. The joggedportion may be located to expose at least a portion of at least a secondelectrode located on the second elongate member as viewed towards thesecond electrode along a direction parallel to a direction that thefirst axis extends along when the structure is in the deployedconfiguration. In some embodiments, the intermediate portion of eachelongate member of the plurality of elongate members includes a frontsurface and a back surface opposite across a thickness of the elongatemember from the front surface. Each intermediate portion furtherincludes a respective pair of side edges of the front surface, the backsurface, or both the front surface and the back surface of theintermediate portion. The side edges of each pair of side edges areopposite to one another, each of the side edges of each pair of sideedges extending between the proximal end and the distal end of therespective elongate member. The first elongate member may be positionedsuch that a first edge of the pair of side edges of the first elongatemember crosses a second side edge of the pair of side edges of thesecond elongate member of the plurality of elongate members when thestructure is in the deployed configuration. A portion of the first edgemay form a recessed portion of the first elongate member that exposes atleast a portion of a second electrode located on a portion of the frontsurface of the second elongate member as viewed normally to the portionof the front surface of the second elongate member when the structure isin the deployed configuration. The second group of the electrodes mayinclude the second electrode.

In some embodiments, each of the respective intermediate portions of theelongate members each may include a thickness, a front surface, and aback surface opposite across the thickness from the front surface. Therespective intermediate portions of the plurality of elongate membersmay be arranged front surface-toward-back surface in a stacked arraywhen the structure is in the delivery configuration. The structure mayfurther include a proximal portion and a distal portion, each of theproximal and the distal portions including a respective part of each ofthe plurality of elongate members, the proximal portion of the structureforming a first domed shape and the distal portion of the structureforming a second domed shape when the structure is in the deployedconfiguration.

The structure may include a proximal portion and a distal portion withthe structure arranged to be advanced distal portion first into thebodily cavity when the structure is in the delivery configuration. Insome embodiments, the proximal portion of the structure forms a firstdomed shape and the distal portion of the structure forms a second domedshape when the structure is in the deployed configuration, the proximaland the distal portions of the structure arranged in a clam shellconfiguration when the structure is in the deployed configuration.

In some embodiments, the intermediate portions of at least some of theplurality of elongate members are, when the structure is in the deployedconfiguration, sufficiently spaced from the first axis to position eachof at least some of the plurality of the electrodes at respectivelocations suitable for contact with a tissue wall of the bodily cavity.

Various systems may include combinations and subsets of the systemssummarized above.

In some embodiments, a medical device system may be summarized asincluding a plurality of transducers positionable in a bodily cavity anda structure on which the transducers are located. The structure includesa plurality of elongate members, each of the elongate members includinga proximal end, a distal end, an intermediate portion positioned betweenthe proximal end and the distal end, and a thickness. Each intermediateportion includes a front surface and a back surface opposite across thethickness of the elongate member from the front surface, and eachintermediate portion further includes a respective pair of side edges ofthe front surface, the back surface, or both the front surface and theback surface. The side edges of each pair of side edges are opposite toone another, and the side edges of each pair of side edges extendbetween the proximal end and the distal end of the respective elongatemember. The structure is selectively moveable between a deliveryconfiguration in which the structure is sized for percutaneous deliveryto a bodily cavity, and a deployed configuration in which the structureis sized too large for percutaneous delivery to the bodily cavity. Atleast a first elongate member of the plurality of elongate members ispositioned such that a first edge of the pair of side edges of the firstelongate member crosses a second side edge of the pair of side edges ofa second elongate member of the plurality of elongate members when thestructure is in the deployed configuration. A portion of the first edgeforms a recessed portion of the first elongate member that exposes atleast a portion of a transducer located on a portion of the frontsurface of the second elongate member as viewed normally to the portionof the front surface of the second elongate member when the structure isin the deployed configuration.

The recessed portion of the first elongate member may form at least aportion of a notch in the intermediate portion of the first elongatemember, the notch extending towards a second edge of the pair of sideedges of the first elongate member. The first elongate member mayinclude a jogged portion, the jogged portion undergoing at least onechange in direction as the jogged portion extends between the proximaland the distal ends of the first elongate member, the recessed portionof the first elongate member forming at least part of the joggedportion.

The intermediate portions of the elongate members may be angularlyarranged with respect to one another about an axis when the structure isin the deployed configuration. At least some of the plurality oftransducers may be radially spaced about an axis when the structure isin the deployed configuration. At least some of the plurality oftransducers may be circumferentially arranged about an axis when thestructure is in the deployed configuration. At least some of theplurality of transducers may be arranged in a plurality of concentricringed arrangements when the structure is in the deployed configuration,a first one of the plurality of concentric ringed arrangements having afewer number of the transducers than a second one of the plurality ofconcentric ringed arrangements. The first one of the plurality ofconcentric ringed arrangements may not include any of the plurality oftransducers located on the second elongate member. The second one of theplurality of concentric ringed arrangements may include the transducerlocated on the portion of the front surface of the second elongatemember. The first one of the plurality of concentric ringed arrangementsmay be adjacent the second one of the plurality of concentric ringedarrangements.

Each of the plurality of elongate members may be arranged to be advanceddistal end-first into the bodily cavity when the structure is in thedelivery configuration. The respective intermediate portions of theplurality of elongate members may be arranged front surface-toward-backsurface in a stacked array when the structure is in the deliveryconfiguration. The structure may further include a proximal portion anda distal portion, each of the proximal and the distal portions includinga respective part of each of the plurality of elongate members, theproximal portion of the structure forming a first domed shape and thedistal portion of the structure forming a second domed shape when thestructure is in the deployed configuration.

The structure may include a proximal portion and a distal portion, withthe structure arranged to be advanced distal portion first into thebodily cavity when the structure is in the delivery configuration. Insome embodiments, the proximal portion of the structure forms a firstdomed shape and the distal portion of the structure forms a second domedshape when the structure is in the deployed configuration, the proximaland the distal portions of the structure arranged in a clam shellconfiguration when the structure is in the deployed configuration.

Various systems may include combinations and subsets of the systemssummarized above.

In some embodiments, a medical device system may be summarized asincluding a plurality of electrodes positionable in a bodily cavity anda structure on which the electrodes are located. The structure includesa plurality of elongate members. The plurality of electrodes include aplurality of sets of the electrodes, each respective set of theelectrodes located on a respective one of the elongate members. Each ofthe elongate members includes a proximal end, a distal end, anintermediate portion positioned between the proximal end and the distalend, and a thickness. Each intermediate portion includes a front surfaceand a back surface opposite across the thickness of the elongate memberfrom the front surface. The structure is selectively moveable between adelivery configuration in which the structure is sized for percutaneousdelivery to the bodily cavity and a deployed configuration in which thestructure is sized too large for percutaneous delivery to the bodilycavity. A first elongate member of the plurality of elongate members ispositioned such that a portion of the front surface of the firstelongate member overlaps a portion of the respective front surface ofeach of at least a second elongate member of the plurality of elongatemembers as viewed normally to the portion of the front surface of thefirst elongate member when the structure is in the deployedconfiguration. At least a first electrode of the plurality of electrodesis located at least on the portion of the front surface of the firstelongate member, and the portion of the front surface of the secondelongate member faces the back surface of the first elongate member atleast when the structure is in the deployed configuration.

Each of the front surfaces of the plurality of elongate members may facean outward direction of the structure when the structure is in thedeployed configuration. The portion of the front surface of the secondelongate member may face the back surface of the first elongate memberwhen the structure is in the delivery configuration. The portion of thefront surface of the second elongate member may contact the back surfaceof the first elongate member when the structure is in the deployedconfiguration. Each electrode in each set of the plurality of electrodesmay be located solely on the front surface of a respective one of theelongate members.

The intermediate portions of the elongate members may be angularlyarranged with respect to one another about an axis when the structure isin the deployed configuration. At least some of the plurality ofelectrodes may be radially spaced about the axis when the structure isin the deployed configuration. At least some of the plurality ofelectrodes may be circumferentially arranged about the axis when thestructure is in the deployed configuration. The intermediate portion ofthe first elongate member may cross the intermediate portion of thesecond elongate member at a location on the structure intersected by theaxis when the structure is in the deployed configuration. Each of theportion of the front surface of the first elongate member and theportion of the front surface of the second elongate member may beintersected by the axis when the structure is in the deployedconfiguration. The intermediate portion of the first elongate member maybe adjacent the intermediate portion of the second elongate member whenthe structure is in the deployed configuration. At least one electrodeof the plurality of electrodes may be intersected by the axis when thestructure is in the deployed configuration. A particular electrode ofthe at least one electrode may be located adjacently to the firstelectrode on the portion of the front surface of the first elongatemember. At least some of the plurality of electrodes may be arranged ina plurality of concentric ringed arrangements when the structure is inthe deployed configuration, a first one of the plurality of concentricringed arrangements having a fewer number of the electrodes than asecond one of the plurality of concentric ringed arrangements. The firstone of the plurality of concentric ringed arrangements may include thefirst electrode.

Each intermediate portion may further include a respective pair of sideedges of the front surface, the back surface, or both the front surfaceand the back surface of the intermediate portion. The side edges of eachpair of side edges are opposite to one another, and each of the sideedges of each pair of side edges extend between the proximal end and thedistal end of the respective elongate member. The first elongate membermay be positioned such that a first edge of the pair of side edges ofthe first elongate member crosses a second side edge of the pair of sideedges of the second elongate member when the structure is in thedeployed configuration. A portion of the first edge may form a recessedportion of the first elongate member that exposes at least a portion ofa second electrode located on the portion of the front surface of thesecond elongate member as viewed normally to the portion of the frontsurface of the second elongate member when the structure is in thedeployed configuration.

Each of the plurality of elongate members may be arranged to be advanceddistal end-first into the bodily cavity when the structure is in thedelivery configuration. The respective intermediate portions of theplurality of elongate members may be arranged front surface-toward-backsurface in a stacked array when the structure is in the deliveryconfiguration. The structure may further include a proximal portion anda distal portion, each of the proximal and the distal portions includinga respective part of each of the plurality of elongate members. In someembodiments, the proximal portion of the structure forms a first domedshape and the distal portion of the structure forms a second domed shapewhen the structure is in the deployed configuration.

The structure may include a proximal portion and a distal portion, withthe structure arranged to be advanced distal portion first into thebodily cavity when the structure is in the delivery configuration. Insome embodiments, the proximal portion of the structure forms a firstdomed shape and the distal portion of the structure forms a second domedshape when the structure is in the deployed configuration, the proximaland the distal portions of the structure arranged in a clam shellconfiguration when the structure is in the deployed configuration.

Various systems may include combinations and subsets of the systemssummarized above.

In some embodiments, a medical device system may be summarized asincluding a plurality of electrodes positionable in a bodily cavity anda structure on which the electrodes are located. The structure includesa plurality of elongate members, each of the elongate members includinga proximal end, a distal end, an intermediate portion positioned betweenthe proximal end and the distal end, and a thickness. Each intermediateportion includes a front surface and a back surface opposite across thethickness of the elongate member from the front surface. Eachintermediate portion further includes a respective pair of side edges ofthe front surface, the back surface, or both the front surface and theback surface. The side edges of each pair of side edges opposite to oneanother. The side edges of each pair of side edges extend between theproximal end and the distal end of the respective elongate member. Thestructure is selectively moveable between a delivery configuration inwhich the structure is sized for percutaneous delivery to a bodilycavity and a deployed configuration in which the structure is sized toolarge for percutaneous delivery to the bodily cavity. At least a firstelongate member of the plurality of elongate members is positioned suchthat a first side edge of the pair of side edges of the first elongatemember crosses a first side edge of the pair of side edges of a secondelongate member of the plurality of elongate members at a first locationand crosses a second side edge of the pair of side edges of the secondelongate member at a second location when the structure is in thedeployed configuration. Each of one or more of the plurality ofelectrodes is wholly located on a portion of the second elongate member,the portion of the second elongate member located between a firsttransverse line and a second transverse line when the structure is inthe deployed configuration, the first transverse line extending across afirst width of the second elongate member at the first location, and thesecond transverse line extending across a second width of the secondelongate member at the second location.

The first width may be different than the second width. The first widthand the second width may be widths of the front surface of the secondelongate member. The one or more electrodes may include two or more ofthe plurality of electrodes. At least a portion of an electrode of theplurality of electrodes may be located on the portion of the secondelongate member.

A first electrode of the one or more of the plurality of electrodes mayinclude a first electrode edge that forms part of a periphery of anelectrically conductive surface of the first electrode, the firstelectrode edge arranged to follow a portion of the first side edge ofthe first elongate member between the first location and the secondlocation when the structure is in the deployed configuration. The firstelectrode may include a second electrode edge opposite across theelectrically conductive surface from the first electrode edge, thesecond electrode edge forming part of the periphery of the electricallyconductive surface of the first electrode. The second electrode edge maybe arranged to follow a portion of one of the pair of side edges of thesecond elongate member.

The intermediate portions of the elongate members may be angularlyarranged with respect to one another about an axis when the structure isin the deployed configuration. At least some of the plurality ofelectrodes may be radially spaced about the axis when the structure isin the deployed configuration. At least some of the plurality ofelectrodes may be circumferentially arranged about the axis when thestructure is in the deployed configuration. The intermediate portion ofthe first elongate member may cross the intermediate portion of thesecond elongate member at a location on the structure intersected by theaxis when the structure is in the deployed configuration. Theintermediate portion of the first elongate member may be adjacent theintermediate portion of the second elongate member when the structure isin the deployed configuration. A particular one of the plurality ofelectrodes may be intersected by the axis when the structure is in thedeployed configuration. The one or more electrodes may include a firstelectrode, the first electrode located on the structure adjacent theparticular one of the plurality of electrodes when the structure is inthe deployed configuration. The one or more electrodes may include afirst electrode, and at least some of the plurality of electrodes may bearranged in a plurality of concentric ringed arrangements when thestructure is in the deployed configuration. In some embodiments, a firstone of the plurality of concentric ringed arrangements has a fewernumber of the electrodes than a second one of the plurality ofconcentric ringed arrangements. The first one of the plurality ofconcentric ringed arrangements may include the first electrode.

A portion of the first side edge of the first elongate member extendingbetween the first location and the second location may form a recessedportion of the first elongate member that exposes at least a portion ofa particular electrode of the one or more electrodes as viewed normallyto a surface of the exposed portion of the particular electrode of theone or more electrodes when the structure is in the deployedconfiguration.

Each of the plurality of elongate members may be arranged to be advanceddistal end-first into the bodily cavity when the structure is in thedelivery configuration. The respective intermediate portions of theplurality of elongate members may be arranged front surface-toward-backsurface in a stacked array when the structure is in the deliveryconfiguration. The structure may further include a proximal portion anda distal portion, each of the proximal and the distal portions includinga respective part of each of the plurality of elongate members. In someembodiments, the proximal portion of the structure forms a first domedshape and the distal portion of the structure forms a second domed shapewhen the structure is in the deployed configuration.

The structure may include a proximal portion and a distal portion, withthe structure arranged to be advanced distal portion first into thebodily cavity when the structure is in the delivery configuration. Insome embodiments, the proximal portion of the structure forms a firstdomed shape and the distal portion of the structure forms a second domedshape when the structure is in the deployed configuration, the proximaland the distal portions of the structure arranged in a clam shellconfiguration when the structure is in the deployed configuration.

Various systems may include combinations and subsets of all the systemssummarized above.

BRIEF DESCRIPTION OF THE DRAWINGS

It is to be understood that the attached drawings are for purposes ofillustrating aspects of various embodiments and may include elementsthat are not to scale.

FIG. 1 is a schematic representation of a transducer-activation systemaccording to example embodiments, the transducer-activation systemincluding a data processing device system, an input-output devicesystem, and a memory device system.

FIG. 2 is a cutaway diagram of a heart showing a transducer-based devicepercutaneously placed in a left atrium of the heart according to exampleembodiments.

FIG. 3A is a partially schematic representation of a medical devicesystem according to example embodiments, the medical device systemincluding a data processing device system, an input-output devicesystem, a memory device system, and a transducer-based device having aplurality of transducers and an expandable structure shown in a deliveryor unexpanded configuration.

FIG. 3B is the medical device system of FIG. 3A with the expandablestructure shown in a deployed or expanded configuration.

FIG. 3C is a representation of the expandable structure of the medicaldevice system of FIG. 3A in the deployed configuration, as viewed from adifferent viewing angle than that employed in FIG. 3B.

FIG. 3D is a plan view of the expandable structure of FIG. 3C.

FIG. 3E is an enlarged view of a portion of the expandable structure ofFIG. 3D.

FIG. 3F is a representation of an expandable structure of atransducer-based device system according to various example embodiments,the expandable structure in a deployed configuration.

FIG. 3G is a plan view of the expandable structure of FIG. 3F.

FIG. 3H is a perspective view of two of the elongate members of theexpandable structure of FIGS. 3F and 3G, each of the elongate membersshown in a flattened configuration.

FIG. 3I is an enlarged view of a portion of the expandable structure ofFIG. 3G.

FIG. 3J is a plan view of the expandable structure of FIG. 3F with anelongate member of the structure omitted for clarity.

FIG. 3K is a perspective view of two elongate members of an expandablestructure of a transducer-based device system according to variousembodiments, each of the elongate members shown in a flattenedconfiguration.

FIG. 4 is a schematic representation of a transducer-based device thatincludes a flexible circuit structure according to at least one exampleembodiment.

DETAILED DESCRIPTION

In the following description, certain specific details are set forth inorder to provide a thorough understanding of various embodiments of theinvention. However, one skilled in the art will understand that theinvention may be practiced without one or more of these details. Inother instances, well-known structures (e.g., structures associated withradio-frequency (RF) ablation and electronic controls such asmultiplexers) have not been shown or described in detail to avoidunnecessarily obscuring descriptions of various embodiments of theinvention.

Reference throughout this specification to “one embodiment” or “anembodiment” or “an example embodiment” or “an illustrated embodiment” or“a particular embodiment” and the like means that a particular feature,structure or characteristic described in connection with the embodimentis included in at least one embodiment. Thus, the appearances of thephrases “in one embodiment” or “in an embodiment” or “in an exampleembodiment” or “in this illustrated embodiment” or “in this particularembodiment” and the like in various places throughout this specificationare not necessarily all referring to the same embodiment. Furthermore,the particular features, structures or characteristics of differentembodiments may be combined in any suitable manner to form one or moreother embodiments.

It is noted that, unless otherwise explicitly noted or required bycontext, the word “or” is used in this disclosure in a non-exclusivesense. In addition, unless otherwise explicitly noted or required bycontext, the word “set” is intended to mean one or more.

Further, the phrase “at least” is used herein at times to emphasize thepossibility that other elements can exist besides those explicitlylisted. However, unless otherwise explicitly noted (such as by the useof the term “only”) or required by context, non-usage herein of thephrase “at least” does not exclude the possibility that other elementscan exist besides those explicitly listed. For example, the phrase,“activation of at least transducer A” includes activation of transducerA by itself, as well as activation of transducer A and activation of oneor more other additional elements besides transducer A. In the samemanner, the phrase, “activation of transducer A” includes activation oftransducer A by itself, as well as activation of transducer A andactivation of one or more other additional elements besides transducerA. However, the phrase, “activation of only transducer A” includes onlyactivation of transducer A, and excludes activation of any otherelements besides transducer A.

The word “ablation” as used in this disclosure should be understood toinclude any disruption to certain properties of tissue. Most commonly,the disruption is to the electrical conductivity and is achieved byheating, which can be generated with resistive or radio-frequency (RF)techniques for example. Other properties, such as mechanical orchemical, and other means of disruption, such as optical, are includedwhen the term “ablation” is used.

The word “fluid” as used in this disclosure should be understood toinclude any fluid that can be contained within a bodily cavity or canflow into or out of, or both into and out of a bodily cavity via one ormore bodily openings positioned in fluid communication with the bodilycavity. In the case of cardiac applications, fluid such as blood willflow into and out of various intra-cardiac cavities (e.g., a left atriumor right atrium).

The words “bodily opening” as used in this disclosure should beunderstood to include a naturally occurring bodily opening or channel orlumen; a bodily opening or channel or lumen formed by an instrument ortool using techniques that can include, but are not limited to,mechanical, thermal, electrical, chemical, and exposure or illuminationtechniques; a bodily opening or channel or lumen formed by trauma to abody; or various combinations of one or more of the above. Variouselements having respective openings, lumens or channels and positionedwithin the bodily opening (e.g., a catheter sheath or catheterintroducer) may be present in various embodiments. These elements mayprovide a passageway through a bodily opening for various devicesemployed in various embodiments.

The words “bodily cavity” as used in this disclosure should beunderstood to mean a cavity in a body. The bodily cavity may be a cavityprovided in a bodily organ (e.g., an intra-cardiac cavity of a heart).

The word “tissue” as used in some embodiments in this disclosure shouldbe understood to include any surface-forming tissue that is used to forma surface of a body or a surface within a bodily cavity, a surface of ananatomical feature or a surface of a feature associated with a bodilyopening positioned in fluid communication with the bodily cavity. Thetissue can include part or all of a tissue wall or membrane that definesa surface of the bodily cavity. In this regard, the tissue can form aninterior surface of the cavity that surrounds a fluid within the cavity.In the case of cardiac applications, tissue can include tissue used toform an interior surface of an intra-cardiac cavity such as a leftatrium or right atrium. In some embodiments, the word tissue can referto a tissue having fluidic properties (e.g., blood).

The term “transducer” as used in this disclosure should be interpretedbroadly as any device capable of distinguishing between fluid andtissue, sensing temperature, creating heat, ablating tissue, measuringelectrical activity of a tissue surface, stimulating tissue, or anycombination thereof. A transducer can convert input energy of one forminto output energy of another form. Without limitation, a transducer caninclude an electrode that functions as, or as part of, a sensing deviceincluded in the transducer, an energy delivery device included in thetransducer, or both a sensing device and an energy delivery deviceincluded in the transducer. A transducer may be constructed from severalparts, which may be discrete components or may be integrally formed.

The term “activation” as used in this disclosure should be interpretedbroadly as making active a particular function as related to varioustransducers disclosed in this disclosure. Particular functions caninclude, but are not limited to, tissue ablation, sensingelectrophysiological activity, sensing temperature and sensingelectrical characteristics (e.g., tissue impedance). For example, insome embodiments, activation of a tissue ablation function of aparticular transducer is initiated by causing energy sufficient fortissue ablation from an energy source device system to be delivered tothe particular transducer. Alternatively, in this example, theactivation can be deemed to be initiated when the particular transducercauses a temperature sufficient for the tissue ablation due to theenergy provided by the energy source device system. Also in thisexample, the activation can last for a duration of time concluding whenthe ablation function is no longer active, such as when energysufficient for the tissue ablation is no longer provided to theparticular transducer. Alternatively, in this example, the activationperiod can be deemed to be concluded when the temperature caused by theparticular transducer is below the temperature sufficient for the tissueablation. In some contexts, however, the word “activation” can merelyrefer to the initiation of the activating of a particular function, asopposed to referring to both the initiation of the activating of theparticular function and the subsequent duration in which the particularfunction is active. In these contexts, the phrase or a phrase similar to“activation initiation” may be used.

The term “program” in this disclosure should be interpreted as a set ofinstructions or modules that can be executed by one or more componentsin a system, such as a controller system or data processing devicesystem, in order to cause the system to perform one or more operations.The set of instructions or modules can be stored by any kind of memorydevice, such as those described subsequently with respect to the memorydevice system 130 shown in FIG. 1. In addition, instructions or modulesof a program may be described as being configured to cause theperformance of a function. The phrase “configured to” in this context isintended to include at least (a) instructions or modules that arepresently in a form executable by one or more data processing devices tocause performance of the function (e.g., in the case where theinstructions or modules are in a compiled and unencrypted form ready forexecution), and (b) instructions or modules that are presently in a formnot executable by the one or more data processing devices, but could betranslated into the form executable by the one or more data processingdevices to cause performance of the function (e.g., in the case wherethe instructions or modules are encrypted in a non-executable manner,but through performance of a decryption process, would be translatedinto a form ready for execution). The word “module” can be defined as aset of instructions.

The word “device” and the phrase “device system” both are intended toinclude one or more physical devices or subdevices (e.g., pieces ofequipment) that interact to perform one or more functions, regardless ofwhether such devices or subdevices are located within a same housing ordifferent housings. In this regard, for example, the phrase “catheterdevice” could equivalently be referred to as a “catheter device system”.

In some contexts, the term “adjacent” is used in this disclosure torefer to objects that do not have another substantially similar objectbetween them. For example, object A and object B could be consideredadjacent if they contact each other (and, thus, it could be consideredthat no other object is between them), or if they do not contact eachother, but no other object that is substantially similar to object A,object B, or both objects A and B, depending on context, is betweenthem.

Further, the phrase “in response to” might be used in the followingcontext, where an event A occurs in response to the occurrence of anevent B. In this regard, such phrase can include, for example, that atleast the occurrence of the event B causes or triggers the event A.

FIG. 1 schematically illustrates a system 100 for activatingtransducers, according to some embodiments. The system 100 includes adata processing device system 110, an input-output device system 120,and a processor-accessible memory device system 130. Theprocessor-accessible memory device system 130 and the input-outputdevice system 120 are communicatively connected to the data processingdevice system 110.

The data processing device system 110 includes one or more dataprocessing devices that implement methods by controlling or interactingwith various structural components described herein, including, but notlimited to, various structural components illustrated in the other FIGS.2-4. Each of the phrases “data processing device”, “data processor”,“processor”, and “computer” is intended to include any data processingdevice, such as a central processing unit (“CPU”), a desktop computer, alaptop computer, a mainframe computer, a tablet computer, a personaldigital assistant, a cellular phone, and any other device for processingdata, managing data, or handling data, whether implemented withelectrical, magnetic, optical, biological components, or otherwise.

The memory device system 130 includes one or more processor-accessiblememory devices configured to store information, including theinformation needed to execute the methods implemented by the dataprocessing device system 110. The memory device system 130 may be adistributed processor-accessible memory device system including multipleprocessor-accessible memory devices communicatively connected to thedata processing device system 110 via a plurality of computers and/ordevices. On the other hand, the memory device system 130 need not be adistributed processor-accessible memory system and, consequently, mayinclude one or more processor-accessible memory devices located within asingle housing or data processing device.

Each of the phrases “processor-accessible memory” and“processor-accessible memory device” is intended to include anyprocessor-accessible data storage device, whether volatile ornonvolatile, electronic, magnetic, optical, or otherwise, including butnot limited to, registers, floppy disks, hard disks, Compact Discs,DVDs, flash memories, ROMs, and RAMs. In some embodiments, each of thephrases “processor-accessible memory” and “processor-accessible memorydevice” is intended to include a non-transitory computer-readablestorage medium. And in some embodiments, the memory device system 130can be considered a non-transitory computer-readable storage mediumsystem.

The phrase “communicatively connected” is intended to include any typeof connection, whether wired or wireless, between devices, dataprocessors, or programs in which data may be communicated. Further, thephrase “communicatively connected” is intended to include a connectionbetween devices or programs within a single data processor, a connectionbetween devices or programs located in different data processors, and aconnection between devices not located in data processors at all. Inthis regard, although the memory device system 130 is shown separatelyfrom the data processing device system 110 and the input-output devicesystem 120, one skilled in the art will appreciate that the memorydevice system 130 may be located completely or partially within the dataprocessing device system 110 or the input-output device system 120.Further in this regard, although the input-output device system 120 isshown separately from the data processing device system 110 and thememory device system 130, one skilled in the art will appreciate thatsuch system may be located completely or partially within the dataprocessing system 110 or the memory device system 130, depending uponthe contents of the input-output device system 120. Further still, thedata processing device system 110, the input-output device system 120,and the memory device system 130 may be located entirely within the samedevice or housing or may be separately located, but communicativelyconnected, among different devices or housings. In the case where thedata processing device system 110, the input-output device system 120,and the memory device system 130 are located within the same device, thesystem 100 of FIG. 1 can be implemented by a single application-specificintegrated circuit (ASIC) in some embodiments.

The input-output device system 120 may include a mouse, a keyboard, atouch screen, another computer, or any device or combination of devicesfrom which a desired selection, desired information, instructions, orany other data is input to the data processing device system 110. Theinput-output device system may include a user-activatable control systemthat is responsive to a user action. The input-output device system 120may include any suitable interface for receiving information,instructions or any data from other devices and systems described invarious ones of the embodiments. In this regard, the input-output devicesystem 120 may include various ones of other systems described invarious embodiments. For example, the input-output device system 120 mayinclude at least a portion of a transducer-based device system. Thephrase “transducer-based device system” is intended to include one ormore physical systems that include one or more physical devices thatinclude transducers.

The input-output device system 120 also may include an image generatingdevice system, a display device system, a processor-accessible memorydevice, or any device or combination of devices to which information,instructions, or any other data is output by the data processing devicesystem 110. In this regard, if the input-output device system 120includes a processor-accessible memory device, such memory device may ormay not form part or all of the memory device system 130. Theinput-output device system 120 may include any suitable interface foroutputting information, instructions or data to other devices andsystems described in various ones of the embodiments. In this regard,the input-output device system may include various other devices orsystems described in various embodiments. For example, the input-outputdevice system may include a portion of a transducer-based device system.

Various embodiments of transducer-based devices are described herein.Some of the described devices are medical devices that arepercutaneously or intravascularly deployed. Some of the describeddevices are moveable between a delivery or unexpanded configuration inwhich a portion of the device is sized for passage through a bodilyopening leading to a bodily cavity, and an expanded or deployedconfiguration in which the portion of the device has a size too largefor passage through the bodily opening leading to the bodily cavity. Anexample of an expanded or deployed configuration is when the portion ofthe transducer-based device is in its intended-deployed-operationalstate inside the bodily cavity. Another example of the expanded ordeployed configuration is when the portion of the transducer-baseddevice is being changed from the delivery configuration to theintended-deployed-operational state to a point where the portion of thedevice now has a size too large for passage through the bodily openingleading to the bodily cavity.

In some example embodiments, the device includes transducers that sensecharacteristics (e.g., convective cooling, permittivity, force) thatdistinguish between fluid, such as a fluidic tissue (e.g., blood), andtissue forming an interior surface of the bodily cavity. Such sensedcharacteristics can allow a medical device system to map the cavity, forexample using positions of openings or ports into and out of the cavityto determine a position or orientation (i.e., pose), or both of theportion of the device in the bodily cavity. In some example embodiments,the described devices are capable of ablating tissue in a desiredpattern within the bodily cavity. In some example embodiments, thedevices are capable of sensing characteristics (e.g.,electrophysiological activity) indicative of whether an ablation hasbeen successful. In some example embodiments, the devices are capable ofproviding stimulation (e.g., electrical stimulation) to tissue withinthe bodily cavity. Electrical stimulation may include pacing.

FIG. 2 shows a transducer-based device 200, which may be all or part ofa medical device system, useful in investigating or treating a bodilyorgan, for example a heart 202, according to some example embodiments.

Transducer-based device 200 can be percutaneously or intravascularlyinserted into a portion of the heart 202, such as an intra-cardiaccavity like left atrium 204. In this example, the transducer-baseddevice 200 is part of a catheter 206 inserted via the inferior vena cava208 and penetrating through a bodily opening in transatrial septum 210from right atrium 212. In other embodiments, other paths may be taken.

Catheter 206 includes an elongated flexible rod or shaft memberappropriately sized to be delivered percutaneously or intravascularly.Various portions of catheter 206 may be steerable. Catheter 206 mayinclude one or more lumens (not shown). The lumen(s) may carry one ormore communications or power paths, or both. For example, the lumens(s)may carry one or more electrical conductors 216 (two shown in thisembodiment). Electrical conductors 216 provide electrical connections todevice 200 that are accessible externally from a patient in which thetransducer-based device 200 is inserted.

Transducer-based device 200 includes a frame or structure 218 whichassumes an unexpanded configuration for delivery to left atrium 204.Structure 218 is expanded (i.e., shown in a deployed or expandedconfiguration in FIG. 2) upon delivery to left atrium 204 to position aplurality of transducers 220 (three called out in FIG. 2) proximate theinterior surface formed by tissue 222 of left atrium 204. In someembodiments, at least some of the transducers 220 are used to sense aphysical characteristic of a fluid (i.e., blood) or tissue 222, or both,that may be used to determine a position or orientation (i.e., pose), orboth, of a portion of a device 200 within, or with respect to leftatrium 204. For example, transducers 220 may be used to determine alocation of pulmonary vein ostia (not shown) or a mitral valve 226, orboth. In some embodiments, at least some of the transducers 220 may beused to selectively ablate portions of the tissue 222. For example, someof the transducers 220 may be used to ablate a pattern or path aroundvarious ones of the bodily openings, ports or pulmonary vein ostia, forinstance to reduce or eliminate the occurrence of atrial fibrillation.

FIGS. 3A, 3B, 3C, 3D and 3E show a transducer-based device system (i.e.,a portion thereof shown schematically) that includes a transducer-baseddevice 300 according to one illustrated embodiment. Transducer-baseddevice 300 includes a plurality of elongate members 304 (three calledout in each of FIGS. 3A and 3B, and three are called out in each ofFIGS. 3C, 3D and 3E as 304 a, 304 b and 304 c) and a plurality oftransducers 306 (three called out in FIG. 3A, three called out in FIG.3B as 306 a, 306 b and 306 c, and seven called out in each of FIGS. 3Cand 3D, six of the seven identified as 306 q, 306 r, 306 s, 306 t, 306 uand 306 v). As will become apparent, the plurality of transducers 306are positionable within a bodily cavity. For example, in someembodiments, the transducers 306 are able to be positioned in a bodilycavity by movement into, within, or into and within the bodily cavity,with or without a change in a configuration of the plurality oftransducers 306. In some embodiments, the plurality of transducers 306are arrangeable to form a two- or three-dimensional distribution, gridor array of the transducers capable of mapping, ablating or stimulatingan inside surface of a bodily cavity or lumen without requiringmechanical scanning. As shown for example, in FIG. 3A, the plurality oftransducers 306 are arranged in a distribution receivable in a bodilycavity (not shown in FIG. 3A). As shown for example, in FIG. 3A, theplurality of transducers 306 are arranged in a distribution suitable fordelivery to a bodily cavity (not shown in FIG. 3A). (It should also benoted, for example, that the expanded or deployed configuration (e.g.,FIGS. 2, 3B-3G, 3I, and 3J) also provide transducers 306 arranged in adistribution receivable in a bodily cavity.)

The elongate members 304 are arranged in a frame or structure 308 thatis selectively movable between an unexpanded or delivery configuration(i.e., as shown in FIG. 3A) and an expanded or deployed configuration(i.e., as shown in FIG. 3B) that may be used to position elongatemembers 304 against a tissue surface within the bodily cavity orposition the elongate members 304 in the vicinity of or in contact withthe tissue surface. In some embodiments, structure 308 has a size in theunexpanded or delivery configuration suitable for percutaneous deliverythrough a bodily opening (i.e., via catheter sheath 312, not shown inFIG. 3B) to the bodily cavity. In some embodiments, structure 308 has asize in the expanded or deployed configuration too large forpercutaneous delivery through a bodily opening (i.e., via cathetersheath 312) to the bodily cavity. The elongate members 304 may form partof a flexible circuit structure (i.e., also known as a flexible printedcircuit board (PCB) circuit). The elongate members 304 can include aplurality of different material layers, and each of the elongate members304 can include a plurality of different material layers. The structure308 can include a shape memory material, for instance Nitinol. Thestructure 308 can include a metallic material, for instance stainlesssteel, or non-metallic material, for instance polyimide, or both ametallic and non metallic material by way of non-limiting example. Theincorporation of a specific material into structure 308 may be motivatedby various factors including the specific requirements of each of theunexpanded or delivery configuration and expanded or deployedconfiguration, the required position or orientation (i.e., pose) or bothof structure 308 in the bodily cavity, or the requirements forsuccessful ablation of a desired pattern.

FIG. 4 is a schematic side elevation view of at least a portion of atransducer-based device 400 that includes a flexible circuit structure401 that is employed to provide a plurality of transducers 406 (twocalled out) according to an example embodiment. In some embodiments, theflexible circuit structure 401 may form part of a structure (e.g.,structure 308) that is selectively movable between a deliveryconfiguration sized for percutaneous delivery and expanded or deployedconfigurations sized too large for percutaneous delivery. In someembodiments, the flexible circuit structure 401 may be located on, orform at least part of, of a structural component (e.g., elongate member304) of a transducer-based device system.

The flexible circuit structure 401 can be formed by various techniquesincluding flexible printed circuit techniques. In some embodiments, theflexible circuit structure 401 includes various layers includingflexible layers 403 a, 403 b and 403 c (i.e., collectively flexiblelayers 403). In some embodiments, each of flexible layers 403 includesan electrical insulator material (e.g., polyimide). One or more of theflexible layers 403 can include a different material than another of theflexible layers 403. In some embodiments, the flexible circuit structure401 includes various electrically conductive layers 404 a, 404 b and 404c (collectively electrically conductive layers 404) that are interleavedwith the flexible layers 403. In some embodiments, each of theelectrically conductive layers 404 is patterned to form variouselectrically conductive elements. For example, electrically conductivelayer 404 a is patterned to form a respective electrode 415 of each ofthe transducers 406. Electrodes 415 have respective electrode edges415-1 that form a periphery of an electrically conductive surfaceassociated with the respective electrode 415. FIG. 3C shows anotherexample of electrode edges 315-1 and illustrates that the electrodeedges can define electrically-conductive-surface-peripheries of variousshapes.

Returning to FIG. 4, electrically conductive layer 404 b is patterned,in some embodiments, to form respective temperature sensors 408 for eachof the transducers 406 as well as various leads 410 a arranged toprovide electrical energy to the temperature sensors 408. In someembodiments, each temperature sensor 408 includes a patterned resistivemember 409 (two called out) having a predetermined electricalresistance. In some embodiments, each resistive member 409 includes ametal having relatively high electrical conductivity characteristics(e.g., copper). In some embodiments, electrically conductive layer 404 cis patterned to provide portions of various leads 410 b arranged toprovide an electrical communication path to electrodes 415. In someembodiments, leads 410 b are arranged to pass though vias (not shown) inflexible layers 403 a and 403 b to connect with electrodes 415. AlthoughFIG. 4 shows flexible layer 403 c as being a bottom-most layer, someembodiments may include one or more additional layers underneathflexible layer 403 c, such as one or more structural layers, such as asteel or composite layer. These one or more structural layers, in someembodiments, are part of the flexible circuit structure 401 and can bepart of, e.g., elongate member 304. In addition, although FIG. 4 showsonly three flexible layers 403 a-403 c and only three electricallyconductive layers 404 a-404 c, it should be noted that other numbers offlexible layers, other numbers of electrically conductive layers, orboth, can be included.

In some embodiments, electrodes 415 are employed to selectively deliverRF energy to various tissue structures within a bodily cavity (notshown) (e.g., an intra-cardiac cavity). The energy delivered to thetissue structures may be sufficient for ablating portions of the tissuestructures. The energy delivered to the tissue may be delivered to causemonopolar tissue ablation, bipolar tissue ablation or blendedmonopolar-bipolar tissue ablation by way of non-limiting example. Insome embodiments, each electrode 415 is employed to sense an electricalpotential in the tissue proximate the electrode 415. In someembodiments, each electrode 415 is employed in the generation of anintra-cardiac electrogram. In some embodiments, each resistive member409 is positioned adjacent a respective one of the electrodes 415. Insome embodiments, each of the resistive members 409 is positioned in astacked or layered array with a respective one of the electrodes 415 toform a respective one of the transducers 406. In some embodiments, theresistive members 409 are connected in series to allow electricalcurrent to pass through all of the resistive members 409. In someembodiments, leads 410 a are arranged to allow for a sampling ofelectrical voltage in between each resistive members 409. Thisarrangement allows for the electrical resistance of each resistivemember 409 to be accurately measured. The ability to accurately measurethe electrical resistance of each resistive member 409 may be motivatedby various reasons including determining temperature values at locationsat least proximate the resistive member 409 based at least on changes inthe resistance caused by convective cooling effects (e.g., as providedby blood flow). In some embodiments in which the transducer-based deviceis deployed in a bodily cavity (e.g., when the transducer-based devicetakes the form of a catheter device arranged to be percutaneously orintravascularly delivered to a bodily cavity), it may be desirable toperform various mapping procedures in the bodily cavity. For example,when the bodily cavity is an intra-cardiac cavity, a desired mappingprocedure can include mapping electrophysiological activity in theintra-cardiac cavity. Other desired mapping procedures can includemapping of various anatomical features within a bodily cavity. Anexample of the mapping performed by devices according to variousembodiments may include locating the position of the ports of variousbodily openings positioned in fluid communication with a bodily cavity.For example, in some embodiments, it may be desired to determine thelocations of various ones of the pulmonary veins or the mitral valvethat each interrupts an interior surface of an intra-cardiac cavity suchas a left atrium.

In some example embodiments, the mapping is based at least on locatingbodily openings by differentiating between fluid and tissue (e.g.,tissue defining a surface of a bodily cavity). There are many ways todifferentiate tissue from a fluid such as blood or to differentiatetissue from a bodily opening in case a fluid is not present. Fourapproaches may include by way of non-limiting example:

1. The use of convective cooling of heated transducer elements by fluid.An arrangement of slightly heated transducers that is positionedadjacent to the tissue that forms the interior surface(s) of a bodilycavity and across the ports of the bodily cavity will be cooler at theareas which are spanning the ports carrying the flow of fluid.

2. The use of tissue impedance measurements. A set of transducerspositioned adjacently to tissue that forms the interior surface(s) of abodily cavity and across the ports of the bodily cavity can beresponsive to electrical tissue impedance. Typically, heart tissue willhave higher associated tissue impedance values than the impedance valuesassociated with blood.

3. The use of the differing change in dielectric constant as a functionof frequency between blood and tissue. A set of transducers positionedaround the tissue that forms the interior surface(s) of the atrium andacross the ports of the atrium monitors the ratio of the dielectricconstant from 1 KHz to 100 KHz. Such can be used to determine which ofthose transducers are not proximate to tissue, which is indicative ofthe locations of the ports.

4. The use of transducers that sense force (i.e., force sensors). A setof force detection transducers positioned around the tissue that formsthe interior surface(s) of a bodily cavity and across the bodilyopenings or ports of the bodily cavity can be used to determine which ofthe transducers are not engaged with the tissue, which may be indicativeof the locations of the ports.

Referring to FIGS. 3A, 3B, transducer-based device 300 can communicatewith, receive power from or be controlled by a transducer-activationsystem 322. In some embodiments, elongate members 304 can form a portionof an elongated cable 316 of control leads 317, for example by stackingmultiple layers, and terminating at a connector 321 or other interfacewith transducer-activation system 322. The control leads 317 maycorrespond to the electrical connectors 216 in FIG. 2 in someembodiments. The transducer-activation device system 322 may include acontroller 324 that includes a data processing device system 310 (e.g.,from FIG. 1) and a memory device system 330 (e.g., from FIG. 1) thatstores data and instructions that are executable by the data processingdevice system 310 to process information received from transducer-baseddevice 300 or to control operation of transducer-based device 300, forexample activating various selected transducers 306 to ablate tissue.Controller 324 may include one or more controllers.

Transducer-activation device system 322 includes an input-output devicesystem 320 (e.g., an example of 120 from FIG. 1) communicativelyconnected to the data processing device system 310 (i.e., via controller324 in some embodiments). Input-output device system 320 may include auser-activatable control that is responsive to a user action.Input-output device system 320 may include one or more user interfacesor input/output (I/O) devices, for example one or more display devicesystems 332, speaker device systems 334, keyboards, mice, joysticks,track pads, touch screens or other transducers to transfer informationto, from, or both to and from a user, for example a care provider suchas a physician or technician. For example, output from a mapping processmay be displayed on a display device system 332.

Transducer-activation device system 322 may also include an energysource device system 340 including one or more energy source devicesconnected to transducers 306. In this regard, although FIG. 3A shows acommunicative connection between the energy source device system 340 andthe controller 324 (and its data processing device system 310), theenergy source device system 340 may also be connected to the transducers306 via a communicative connection that is independent of thecommunicative connection with the controller 324 (and its dataprocessing device system 310). For example, the energy source devicesystem 340 may receive control signals via the communicative connectionwith the controller 324 (and its data processing device system 310),and, in response to such control signals, deliver energy to, receiveenergy from, or both deliver energy to and receive energy from one ormore of the transducers 306 via a communicative connection with suchtransducers 306 (e.g., via one or more communication lines throughcatheter body 314, elongated cable 316 or catheter sheath 312) that doesnot pass through the controller 324. In this regard, the energy sourcedevice system 340 may provide results of its delivering energy to,receiving energy from, or both delivering energy to and receiving energyfrom one or more of the transducers 306 to the controller 324 (and itsdata processing device system 310) via the communicative connectionbetween the energy source device system 340 and the controller 324.

In any event, the number of energy source devices in the energy sourcedevice system 340 is fewer than the number of transducers in someembodiments. The energy source device system 340 may, for example, beconnected to various selected transducers 306 to selectively provideenergy in the form of electrical current or power (e.g., RF energy),light or low temperature fluid to the various selected transducers 306to cause ablation of tissue. The energy source device system 340 may,for example, selectively provide energy in the form of electricalcurrent to various selected transducers 306 and measure a temperaturecharacteristic, an electrical characteristic, or both at a respectivelocation at least proximate each of the various transducers 306. Theenergy source device system 340 may include as its energy source devicesvarious electrical current sources or electrical power sources. In someembodiments, an indifferent electrode 326 is provided to receive atleast a portion of the energy transmitted by at least some of thetransducers 306. Consequently, although not shown in FIG. 3A, theindifferent electrode 326 may be communicatively connected to the energysource device system 340 via one or more communication lines in someembodiments. In addition, although shown separately in FIG. 3A,indifferent electrode 326 may be considered part of the energy sourcedevice system 340 in some embodiments.

It is understood that input-output device system 320 may include othersystems. In some embodiments, input-output device system 320 mayoptionally include energy source device system 340, transducer-baseddevice 300 or both energy source device system 340 and transducer-baseddevice 300 by way of non-limiting example.

Structure 308 can be delivered and retrieved via a catheter member, forexample a catheter sheath 312. In some embodiments, a structure providesexpansion and contraction capabilities for a portion of a medical device(e.g., an arrangement, distribution or array of transducers 306). Thetransducers 306 can form part of, be positioned or located on, mountedor otherwise carried on the structure and the structure may beconfigurable to be appropriately sized to slide within catheter sheath312 in order to be deployed percutaneously or intravascularly. FIG. 3Ashows one embodiment of such a structure. In some embodiments, each ofthe elongate members 304 includes a respective distal end 305 (only onecalled out), a respective proximal end 307 (only one called out) and anintermediate portion 309 (only one called out) positioned between theproximal end 307 and the distal end 305. The respective intermediateportion 309 of each elongate member 304 includes a first or frontsurface 318 a that is positionable to face an interior tissue surfacewithin a bodily cavity (not shown) and a second or back surface 318 bopposite across a thickness of the intermediate portion 309 from thefront surface 318 a. In various embodiments, the intermediate portion309 of each of the elongate members 304 includes a respective pair ofside edges of the front surface 318 a, the back surface 318 b, or boththe front surface 318 a and the back surface 318 b, the side edges ofeach pair of side edges opposite to one another, the side edges of eachpair of side edges extending between the proximal end 307 and the distalend 305 of the respective elongate member 304. In some embodiments, eachpair of side edges includes a first side edge 327 a (only one called outin FIG. 3A) and a second side edge 327 b (only one called out in FIG.3A). In some embodiments, each of the elongate members 304, includingeach respective intermediate portion 309, is arranged front surface 318a-toward-back surface 318 b in a stacked array during an unexpanded ordelivery configuration similar to that described in co-assignedInternational Application No.: PCT/US2012/022061 and co-assignedInternational Application No.: PCT/US2012/022062. In many cases astacked array allows the structure 308 to have a suitable size forpercutaneous or intravascular delivery. In some embodiments, theelongate members 304 are arranged to be introduced into a bodily cavity(again not shown in FIG. 3A) distal end 305 first. For clarity, not allof the elongate members 304 of structure 308 are shown in FIG. 3A. Aflexible catheter body 314 is used to deliver structure 308 throughcatheter sheath 312. In some embodiments, each elongate member includesa twisted portion proximate at proximal end 307. Similar twistedportions are described in co-assigned International Application No.:PCT/US2012/022061 and co-assigned International Application No.:PCT/US2012/022062.

In a manner similar to that described in co-assigned InternationalApplication No.: PCT/US2012/022061 and co-assigned InternationalApplication No.: PCT/US2012/022062, each of the elongate members 304 isarranged in a fanned arrangement 370 in FIG. 3B. In some embodiments,the fanned arrangement 370 is formed during the expanded or deployedconfiguration in which structure 308 is manipulated to have a size toolarge for percutaneous or intravascular delivery. In some embodiments,structure 308 includes a proximal portion 308 a having a first domedshape 309 a and a distal portion 308 b having a second domed shape 309b. In some embodiments, the proximal and the distal portions 308 a, 308b include respective portions of elongate members 304. In someembodiments, the structure 308 is arranged to be delivered distalportion 308 b first into a bodily cavity (again not shown) when thestructure is in the unexpanded or delivery configuration as shown inFIG. 3A. In some embodiments, the proximal and the distal portions 308a, 308 b are arranged in a clam shell configuration in the expanded ordeployed configuration shown in FIG. 3B. In various example embodiments,each of the front surfaces 318 a (three called out in FIG. 3B) of theintermediate portions 309 of the plurality of elongate members 304 faceoutwardly from the structure 308 when the structure 308 is in thedeployed configuration. In various example embodiments, each of thefront surfaces 318 a of the intermediate portions 309 of the pluralityof elongate members 304 are positioned adjacent an interior tissuesurface of a bodily cavity (not shown) in which the structure 308 (i.e.,in the deployed configuration) is located. In various exampleembodiments, each of the back surfaces 318 b (two called out in FIG. 3B)of the intermediate portions 309 of the plurality of elongate members304 face an inward direction when the structure 308 is in the deployedconfiguration.

The transducers 306 can be arranged in various distributions orarrangements in various embodiments. In some embodiments, various onesof the transducers 306 are spaced apart from one another in a spacedapart distribution in the delivery configuration shown in FIG. 3A. Insome embodiments, various ones of the transducers 306 are arranged in aspaced apart distribution in the deployed configuration shown in FIG.3B. In some embodiments, various pairs of transducers 306 are spacedapart with respect to one another. In some embodiments, various regionsof space are located between various pairs of the transducers 306. Forexample, in FIG. 3B the transducer-based device 300 includes at least afirst transducer 306 a, a second transducer 306 b and a third transducer306 c (all collectively referred to as transducers 306). In someembodiments each of the first, the second, and the third transducers 306a, 306 b and 306 c are adjacent transducers in the spaced apartdistribution. In some embodiments, the first and the second transducers306 a, 306 b are located on different elongate members 304 while thesecond and the third transducers 306 b, 306 c are located on a sameelongate member 304. In some embodiments, a first region of space 350 isbetween the first and the second transducers 306 a, 306 b. In someembodiments, the first region of space 350 is not associated with anyphysical portion of structure 308. In some embodiments, a second regionof space 360 associated with a physical portion of device 300 (i.e., aportion of an elongate member 304) is between the second and the thirdtransducers 306 b, 306 c. In some embodiments, each of the first and thesecond regions of space 350, 360 does not include a transducer oftransducer-based device 300. In some embodiments, each of the first andthe second regions of space 350, 360 does not include any transducer. Itis noted that other embodiments need not employ a group of elongatemembers 304 as employed in the illustrated embodiment. For example,other embodiments may employ a structure having one or more surfaces, atleast a portion of the one or more surfaces defining one or moreopenings in the structure. In these embodiments, a region of space notassociated with any physical portion of the structure may extend over atleast part of an opening of the one or more openings. In other exampleembodiments, other structures may be employed to support or carrytransducers of a transducer-based device such as a transducer-basedcatheter. For example, an elongated catheter member may be used todistribute the transducers in a linear or curvilinear array. Basketcatheters or balloon catheters may be used to distribute the transducersin a two-dimensional or three-dimensional array.

In various example embodiments, at least some of the plurality oftransducers 306 include respective electrodes 315 (seven called out ineach of FIGS. 3C, 3D, six of the seven called out as 315 q, 315 r, 315s, 315 t, 315 u and 315 v), each electrode 315 including a respectiveenergy transmission surface 319 (one called out in FIG. 3C, three calledout in FIG. 3D, two of the three called out as 319 u, 319 v) configuredfor transferring energy to tissue, from tissue or both to and fromtissue. In various embodiments, each of the energy transmission surfaces319 is provided by an electrically conductive surface. In someembodiments, each of the electrodes 315 is solely located on a surfaceof an elongate member 304 (e.g., front surfaces 318 a or back surfaces318 b). In some embodiments, various electrodes 315 are located on one,but not both of the respective front surface 318 a and respective backsurface 318 b of each of various ones of the elongate members 304.

Various conventional percutaneous or intravascular transducer-baseddevice systems employ, or have employed, relatively low numbers oftransducers typically on the order of 64 or fewer transducers or anumber of transducers arranged with a relatively low spatialdistribution density (e.g., a relatively low number of transducersarranged per a given area). Various embodiments disclosed in thisdetailed description may employ distributions of transducers havingrelatively high spatial densities (e.g., a relatively high number oftransducers arranged per a given region of space) than conventionallyemployed. Increased number of transducers or increased spatial densitiesof transducers within a particular distribution of the transducers maybe motivated for various reasons. For example, increased numbers oftransducers may allow for higher spatial densities in the distributionsof the transducers to allow the transducers to interact with a tissueregion of a bodily cavity with greater resolution and accuracy. Theinteractions may include ablation, temperature detection, impedancedetection, electrophysiological activity detection and tissuestimulation by way of non-limiting example. In some case, distributionsof transducers having relatively high spatial densities may provideenhanced diagnostic or treatment procedures performed on a given tissueregion by allowing for the interaction of a greater number oftransducers with the given tissue region. Various embodiments disclosedin this detailed description may employ 100 or more transducers, 200 ormore transducers or even 300 or more transducers. Varioustransducer-based devices disclosed in this detailed description (e.g.,as depicted at least in part in FIGS. 3A, 3B, 3C, 3D, 3E, 3F, 3G, 3H,3I, 3J and 3K) are representative of various embodiments that employseveral hundreds of transducers. Various transducer-based devicesdisclosed in this detailed description (e.g., as depicted at least inpart in FIGS. 3A, 3B, 3C, 3D, 3E, 3F, 3G, 3H, 3I, 3J and 3K) arerepresentative of various embodiments that employ distributions oftransducers having relatively higher spatial densities. Althoughtransducers 306, electrodes 315 or both transducers 306 and electrodes315 are referenced with respect to various embodiments, it is understoodthat other transducers or transducer elements may be employed in otherembodiments. It is understood that a reference to a particulartransducer 306 in various embodiments may also imply a reference to anelectrode 315, as an electrode 315 may be part of the transducer 306 asshown, e.g., with FIG. 4.

FIG. 3C is a perspective view of at least one embodiment of thetransducer-based device 300 as viewed from a viewing angle that isdifferent from that shown in FIG. 3B. For clarity of illustration, onlystructure 308 including various ones of the elongate members 304, and aportion of catheter body 314 are shown in FIG. 3C. In a manner similarto that shown in FIG. 3B, transducer-based device 300 is shown in theexpanded or deployed configuration. In some embodiments, the respectiveintermediate portions 309 (only two called out) of various ones of theelongate members 304 are angularly arranged with respect to one anotherabout a first axis 335 a when structure 308 is in the deployedconfiguration. In various embodiments, the respective intermediateportions 309 of a respective pair of the elongate members 304 areangularly spaced with respect to one another by a respective angleradiating from a point on the first axis 335 a when structure 308 is inthe deployed configuration. The same may apply for each pair of adjacentelongate members 304 in some embodiments. In various embodiments, theintermediate portions 309 of various ones of the elongate members 304are radially arranged about first axis 335 a when structure 308 is inthe deployed configuration. In various embodiments, the intermediateportions 309 of various ones of the elongate members 304 arecircumferentially arranged about first axis 335 a when structure 308 isin the deployed configuration, similar to lines of longitude about anaxis of rotation of a body of revolution, which body of revolution may,or may not be spherical. Use of the word circumference in this detaileddescription, and derivatives thereof, such as circumferential,circumscribe, circumlocutory and other derivatives, refers to a boundaryline of a shape, volume or object which may, or may not, be circular orspherical. In some embodiments, each of the elongate members 304includes a curved portion 323 (only two called out) having a curvatureconfigured to cause the curved portion 323 to extend along at least aportion of a curved path, the curvature configured to cause the curvedpath to intersect the first axis 335 a at each of a respective at leasttwo spaced apart locations along the first axis 335 a when structure 308is in the deployed configuration. In some embodiments, the curved pathis defined to include an imagined extension of the curved portion alongthe curved portion's extension direction while maintaining the curvedportion's curvature. In some embodiments, each curved portion 323 mayextend entirely along, or at least part way along the respective curvedpath to physically intersect at least one of the respective at least twospaced apart locations along the first axis 335 a. In some particularembodiments, no physical portion of a given elongate member of anemployed structure intersects any of the at least two spaced apartlocations along the first axis 335 a intersected by the respectivecurved path associated with the curved portion 323 of the given elongatemember. For example, the end portion of the given elongate member may bephysically separated from the first axis 335 a by hub system (not shown)employed to physically couple or align the elongate member to otherelongate members. Additionally or alternatively, a given elongate membermay include a recurve portion arranged to physically separate the givenelongate member from the first axis 335 a. In some embodiments, variousones of the elongate members 304 cross one another at a location on thestructure 308 passed through by the first axis 335 a when the structure308 is in the deployed configuration. In various embodiments, the curvedpath is an arcuate path. In various embodiments, at least the portion ofthe curved path extended along by corresponding curved portion 323 isarcuate. As used herein, the word “curvature” should be understood tomean a measure or amount of curving. In some embodiments, the word“curvature” is associated with a rate of change of the angle throughwhich the tangent to a curve turns in moving along the curve.

In some embodiments, the intermediate portion 309 of first elongatemember 304 a overlaps the intermediate portion 309 of a second elongatemember 304 b at a location on structure 308 passed through by first axis335 a when structure 308 is in the deployed configuration. In someembodiments, the intermediate portions 309 of the first elongate member304 a and the second elongate member 304 b cross at a location onstructure 308 passed through, or intersected, by first axis 335 a whenstructure 308 is in the deployed configuration. In some embodiments, theintermediate portion 309 of first elongate member 304 a is adjacent theintermediate portion 309 of the second elongate member 304 b whenstructure 308 is in the deployed configuration. In various embodiments,the intermediate portions 309 of at least some of the plurality ofelongate members 304 are, when the structure 309 is in the deployedconfiguration, sufficiently spaced from the first axis 335 a to positioneach of at least some of the plurality of the electrodes 315 atrespective locations suitable for contact with a tissue wall of thebodily cavity (not shown in FIG. 3C).

In various embodiments, at least some of the transducers 306 areradially spaced about first axis 335 a when structure 308 is in thedeployed configuration. For example, various ones of the electrodes 315are radially spaced about first axis 335 a in the deployed configurationin at least some of the embodiments associated with various ones ofFIGS. 3B, 3C, 3D and 3E. In various embodiments, at least some of thetransducers 306 are circumferentially arranged about first axis 335 awhen structure 308 is in the deployed configuration. For example,various ones of the electrodes 315 are circumferentially arranged aboutfirst axis 335 a in the deployed configuration in at least some of theembodiments associated with various ones of FIGS. 3B, 3C, 3D and 3E.Various methods may be employed to describe the various spatialrelationships of the transducers 306 or electrodes 315 or various setsof transducers 306 or sets of electrodes 315 employed according tovarious embodiments. For example, in FIGS. 3C and 3D the plurality ofthe electrodes 315 includes a first group 336 a (not called out in FIG.3E) of the electrodes 315 located on first elongate member 304 a and asecond group 338 a (not called out in FIG. 3E) of the electrodes 315located on second elongate member 304 b. It is understood that althoughelectrodes are referred to in these described embodiments, the sameanalysis applies to the corresponding transducers in some embodiments.It is understood that although groups of electrodes are referred to inthese described embodiments, the plurality of electrodes 315 may formpart of a plurality of sets of one or more of the electrodes 315, eachrespective set of the electrodes 315 located on a respective one of theelongate members 304 in other embodiments. The electrodes 315 of thefirst group 336 a are arranged such that each electrode 315 of the firstgroup 336 a is intersected by a first plane 342 a having no thickness.The phrase “no thickness” in this and similar contexts means nothickness, practically no thickness, or infinitely small thickness, andexcludes perceptibly large thicknesses like thicknesses on the order ofa size of an electrode 315. The electrodes 315 of the second group 338 aare arranged such that each electrode 315 of the second group 338 a isintersected by a second plane 344 a having no thickness. For clarity,the intersection of each electrode 315 of the first group 336 a by firstplane 342 a is represented in FIG. 3C by intersection line 345 a. Forclarity, the intersection of each electrode 315 of the second group 338a by second plane 344 a is represented in FIG. 3C by intersection line345 b. First plane 342 a and second plane 344 a are depicted as havingboundaries merely for purposes of clarity of illustration in FIG. 3C.

Each of the first plane 342 a and the second plane 344 a arenon-parallel planes that intersect each other along a second axis 337 a.In some embodiments, second axis 337 a is parallel to first axis 335 a.In some embodiments, first axis 335 a and second axis 337 a arecollinear. In some embodiments, the first axis 335 a and the second axis337 a form a single axis. In other embodiments, different spatialrelationships may exist between first axis 335 a and second axis 337 a.In some embodiments, the electrodes 315 are arranged in a spatialdistribution in which a first electrode 315 q associated with transducer306 q is intersected by each of the first plane 342 a and the secondplane 344 a when the structure 308 is in the deployed configuration. Insome embodiments, first electrode 315 q is not intersected by first axis335 a when structure 308 is in the deployed configuration. In someembodiments, first electrode 315 q is not intersected by second axis 337a when structure 308 is in the deployed configuration. In someembodiments, the first group 336 a of electrodes 315 includes firstelectrode 315 q. In some embodiments, the second group of electrodes 338a does not include first electrode 315 q. In various embodiments, thefirst axis 335 a, the second axis 337 a or each of the first axis 335 aand the second axis 337 a intersects at least one electrode 315 locatedon structure 308 (e.g., electrode 315 r associated with transducer 306 rin FIGS. 3C and 3D) that does not include first electrode 315 q. In someembodiments, the first axis 335 a, the second axis 337 a or each of thefirst axis 335 a and the second axis 337 a does not intersect anyelectrode 315 located on structure 308, such as, for example, when nopolar electrode (e.g., 315 r in FIGS. 3C and 3D) is provided. In someembodiments, the first axis 335 a, the second axis 337 a or each of thefirst axis 335 a and the second axis 337 a does not intersect anyelectrode or transducer.

FIG. 3D is a plan view of structure 308 in the deployed configuration ofFIG. 3C. The plan view of FIG. 3D has an orientation such that each offirst plane 342 a and second plane 344 a is viewed ‘on edge’ to theirrespective planar surfaces. (Note that in embodiments where each of thefirst plane 342 a and the second plane 344 a have no thickness, ‘onedge’ is intended to refer to an ‘on edge’ perspective assuming thateach plane had an edge of minimal thickness.) The plan view of FIG. 3Dhas an orientation such that each of the first axis 335 a and secondaxis 337 a is viewed along the axis in this particular embodiment. Eachof first plane 342 a and second plane 344 a are represented by arespective “heavier” line in FIG. 3D. Each of first axis 335 a andsecond axis 337 a are represented by a “•” symbol in FIG. 3D. It isunderstood that each of the depicted lines or symbols “•” used torepresent any corresponding plane, intersection line or axis in thisdisclosure do not impart any size attributes on the corresponding planeor axis.

In various embodiments, each of the first group 336 a and the secondgroup 338 a includes two or more of the electrodes 315. In someembodiments, the first group 336 a, the second group 338 a or each ofboth the first group 336 a and the second group 338 a includes three ormore of the electrodes 315. In various embodiments, the first group 336a, the second group 338 a or each of both the first group 336 a and thesecond group 338 a includes a pair of adjacent electrodes 315 located ona respective one of the first elongate member 304 a and the secondelongate member 304 b. In some of these various embodiments, a region ofspace associated with a physical portion of structure 308 (e.g., anelongate member 304 portion) is located between the respectiveelectrodes 315 of the pair of adjacent electrodes 315 included in thefirst group 336 a, and the region of space is intersected by the firstplane 342 a when the structure 308 is in the deployed configuration. Insome embodiments, the respective electrodes 315 of the first group 336 aare spaced along a length of a portion of the first elongate member 304a, the length extending between the respective distal and proximal ends305, 307 (not called out in FIGS. 3B, 3C, 3D and 3E) of the firstelongate member 304 a, the entirety of the length of the portion of thefirst elongate member 304 a being intersected by the first plane 342 awhen structure 308 is in the deployed configuration. In someembodiments, the first plane 342 a intersects every electrode 315located on the first elongate member 304 a when structure 308 is in thedeployed configuration. In some embodiments, the second plane 344 aintersects every electrode 315 that is located on the second elongatemember 304 b when structure 308 is in the deployed configuration. Insome embodiments, some, but not all of the respective electrodes 315located on the first elongate member 304 a, the second elongate member304 b, or each of the first elongate member 304 a and the secondelongate member 304 b are intersected by a corresponding one of thefirst plane 342 a and the second plane 344 a when structure 308 is inthe deployed configuration.

In some embodiments, the second axis 337 a is not collinear with thefirst axis 335 a. In some embodiments, the second axis 337 a and thefirst axis 335 a do not form a single axis. In some embodiments, thesecond axis 337 a does not intersect the first axis 335 a. FIG. 3D showsanother embodiment in which each electrode 315 of second group 338 b(not called out in FIGS. 3C and 3E) of electrodes 315 located on secondelongate member 304 b is intersected by a second plane 344 b having nothickness. Second plane 344 b is viewed transversely to its planarsurface in FIG. 3D and is represented by a line. Although second plane344 b is depicted parallel to second plane 344 a in FIG. 3D, differentorientations may be employed in other embodiments. First plane 342 a andsecond plane 344 b are non parallel planes that intersect one anotheralong a second axis 337 b represented by a symbol “•” in FIG. 3D. Forclarity, each of second plane 344 b and second axis 337 b is not shownin FIG. 3C. In at least one particular embodiment associated with FIG.3D, each of the first plane 342 a and the second plane 344 b intersectsa first electrode 315 s associated with transducer 306 s that is notintersected by the second axis 337 b. In at least one particularembodiment associated with FIG. 3D, first electrode 315 s is notintersected by the first axis 335 a. In at least one particularembodiment associated with FIG. 3D, first electrode 315 s is notintersected by the second axis 337 b. In at least one particularembodiment associated with FIG. 3D, second axis 337 b intersects atleast one other electrode (e.g., electrode 315 t associated withtransducer 306 t). In at least one particular embodiment associated withFIG. 3D, the intermediate portion 309 of the first elongate member 304 aoverlaps the intermediate portion 309 of the second elongate member 304b at each of a first location on structure 308 passed through by firstaxis 335 a and a second location on structure 308 passed through by thesecond axis 337 b when structure 308 is in the deployed configuration,the second and first locations being different locations.

In various embodiments, particular spatial distributions of electrodesor transducers similar to the ones employed in FIGS. 3A, 3B, 3C, 3D and3E may advantageously allow for higher spatial densities of theelectrodes or transducers to be employed. For example, as best seen inFIGS. 3C and 3D, various distributions of electrodes 315 havingrelatively high spatial densities are created throughout a significantportion of structure 308 including various regions proximate first axis335 a. It is noted that portions of various ones of elongate members 304shown in FIGS. 3C and 3D overlap one another as the portions approachfirst axis 335 a when structure 308 is in the deployed configuration. Invarious embodiments, overlapping elongate members 304 may be employed atleast in part to provide to distributions of the electrodes 315 havinghigher spatial densities. In FIGS. 3C and 3D, a portion of a firstelongate member 304 (e.g., elongate member 304 a) is shown overlapping aportion of at least a second elongate member 304 (e.g., elongate member304 b) when structure 308 is in the deployed configuration. FIG. 3Eincludes an enlarged view of a portion of the structure 308 depicted inFIG. 3D, the portion of structure 308 including portions of at leastelongate members 304 a and 304 b. For clarity of illustration, planes342 a, 344 a, 344 b and axis 337 b are not shown in FIG. 3E. In at leastone particular embodiment associated with FIG. 3E, a portion 346 a(i.e., only called out in FIG. 3E) of the front surface of 318 a offirst elongate member 304 a overlaps a portion 347 a (i.e., only calledout in FIG. 3E, partially bounded by a ghosted line 345 a for clarity)of the front surface 318 a of second elongate member 304 b as viewednormally to the portion 346 a of the front surface 318 a of firstelongate member 304 a when structure 308 is in the deployedconfiguration. In this particular embodiment, the spatial density of thedistribution of transducers 306/electrodes 315 is such that at least afirst electrode (e.g., electrode 315 q associated with transducer 306 q)is located at least on the portion 346 a of the front surface 318 a offirst elongate member 304 a. In some embodiments, the portion of 347 aof the front surface 318 a of second elongate member 304 b faces theback surface 318 b (not called out in FIG. 3E) of first elongate member304 a when structure 308 is in the deployed configuration. In someembodiments, the portion of 347 a of the front surface 318 a of secondelongate member 304 b faces the back surface 318 b of first elongatemember 304 a when structure 308 is in the delivery configuration (e.g.,when the elongate members 304 are arranged front surface-toward-backsurface in a stacked array (e.g., when the structure 308 is in adelivery configuration similar to that depicted in FIG. 3A). In someexample embodiments, the portion 347 a of the front surface 318 a ofsecond elongate member 304 b contacts the back surface 318 b of firstelongate member 304 a when structure 308 is in the deployedconfiguration. In a similar manner, a portion 346 b (i.e., only calledout in FIG. 3E) of the front surface of 318 a of elongate member 304 boverlaps a portion 347 b (i.e., only called out in FIG. 3E, partiallybounded by a ghosted line 345 b for clarity) of the front surface 318 aof elongate member 304 c as viewed normally to the portion 346 b of thefront surface 318 a of elongate member 304 b when structure 308 is inthe deployed configuration. In this case, a first electrode (e.g.,electrode 316 u associated with transducer 306 u) is located at least onthe portion 346 b of the front surface 318 a of elongate member 304 b.

Other spatial characteristics are associated with the distribution oftransducers 306/electrodes 315 associated with various embodimentsassociated with FIGS. 3A, 3B, 3C, 3D and 3E. For example, as best seenin FIG. 3E, a first side edge 327 a of the first elongate member 304 acrosses a first side edge 327 a of the pair of side edges of the secondelongate member 304 b at a first location 351 a and crosses a secondside edge 327 b of the pair of side edges of the second elongate member304 b at a second location 352 a when structure 308 is in the deployedconfiguration. In various embodiments associated with FIG. 3E, variouselectrodes 315 are located at least on a portion 348 a of the secondelongate member 304 b, the portion 348 a of the second elongate member304 b located between a first transverse line 349 a and a secondtransverse line 349 b (e.g., each depicted by a ghosted line in FIG. 3E)when the structure 308 is in the deployed configuration. In variousembodiments associated with FIG. 3E, the first transverse line 349 aextends across a first width 353 a of the second elongate member 304 bat the first location 351 a, and the second transverse line 349 bextends across a second width 353 b of the second elongate member 304 bat the second location 352 a. In at least one particular embodimentassociated with FIG. 3E, the first width 353 a and the second width 353b are the widths of the front surfaces 318 a of the second elongatemember 304 b. In at least one particular embodiment associated with FIG.3E, a magnitude of first width 353 a is substantially the same as amagnitude of the second width 353 b. In some embodiments, the magnitudeof the first width 353 a is different than the magnitude of the secondwidth 353 b. In some embodiments, the first transverse line 349 a isperpendicular to one or both of the side edges 327 a, 327 b of thesecond elongate member 304 b. Similarly, in some embodiments, the secondtransverse line 349 b is perpendicular to one or both of the side edges327 a, 327 b of the second elongate member 304 b. In some embodiments,the magnitude of the first width 353 a is a minimum with respect to allother respective magnitudes of possible widths between side edges 327 a,327 b of the second elongate member 304 b originating at location 351 a.Similarly, in some embodiments, the magnitude of the second width 353 bis a minimum with respect to all other respective magnitudes of possiblewidths between side edges 327 a, 327 b of the second elongate member 304b originating at location 352 a.

In some example embodiments, one or more of the electrodes 315 arewholly located on the portion 348 a of the second elongate member 304 bwhen the structure 308 is in the deployed configuration. For example,electrode 315 u is wholly located on the portion 348 a (which isrectangular in some embodiments such as FIG. 3E) of the second elongatemember 304 b when the structure 308 is in the deployed configuration. Insome example embodiments, at least a portion of an electrode 315 of theplurality of electrodes 315 is located on the portion 348 a of thesecond elongate member 304 b when structure 308 is in the deployedconfiguration. As shown, for example, in FIG. 3E, electrode 315 v islocated at least on portion 348 a in the deployed configuration. Invarious other embodiments, two or more of the electrodes 315 may belocated on the portion 348 a of the second elongate member 304 b.

It may be noted that distances between adjacent ones of the elongatemembers 304 shown in FIGS. 3C, 3D and 3E vary as elongate members 304extend towards first axis 335 a when structure 308 is in the deployedconfiguration. In some cases, the varying distances between adjacentelongate members 304 in the deployed configuration may give rise toshape, size or dimensional constraints for the electrodes 315 located onthe elongate members 304. In some cases, the overlapping portions ofvarious ones the elongate members 304 in the deployed configuration maygive rise to shape, size or dimensional constraints for the electrodes315 located on the portions of the various ones of the elongate members304. For example, it may be desirable to reduce a surface area of anelectrode adjacent an overlap region on an overlapped elongate member toaccommodate the reduced-exposed-surface area of the overlapped elongatemember in the region adjacent the overlap region (e.g., electrode 315 uin FIG. 3E).

In various embodiments, the respective shape of various electricallyconductive surfaces (e.g., energy transmission surfaces 319) of variousones of the electrodes 315 vary among the electrodes 315. In variousembodiments, the respective shape of various electrically conductivesurfaces (e.g., energy transmission surfaces 319) of various ones of theelectrodes 315 vary among the electrodes 315 in accordance with theirproximity to first axis 335 a. In various embodiments, one or moredimensions or sizes of various electrically conductive surfaces (e.g.,energy transmission surfaces 319) of various ones of the electrodes 315vary among the electrodes 315. In various embodiments, one or moredimensional sizes of various electrically conductive surfaces (e.g.,energy transmission surfaces 319) of various ones of the electrodes 315vary in accordance with their proximity to first axis 335 a. The shapeor size variances associated with various ones of the electrodes 315 maybe motivated for various reasons. For example, in various embodiments,the shapes or sizes of various ones of the electrodes 315 may becontrolled in response to various ones of the aforementioned size ordimensional constraints.

Referring to FIG. 3E, it is noted that each of various ones of theelectrodes 315 (e.g., electrodes 315 u and 315 v) located at least onsecond elongate member 304 b have various electrode edges (e.g., 315-1in FIG. 3C or 415-1 in FIG. 4) that form a periphery of an electricallyconductive surface associated with each of the various electrodes 315(e.g., an energy transmission surface 319). In at least one particularembodiment associated with FIG. 3E, a first electrode edge 333 aassociated with electrode 315 u is arranged to follow a portion of thefirst side edge 327 a of the first elongate member 304 a between thefirst location 351 a and the second location 352 a when the structure308 is an expanded or deployed configuration. In some embodiments, thefirst electrode edge 333 a of electrode 315 u is arranged to be parallelto the portion of the first side edge 327 a of the first elongate member304 between the first location 351 and the second location 352 when thestructure 308 is in an expanded or deployed configuration. In thisparticular embodiment, a second electrode edge 333 b forming part of theperiphery of electrically conductive surface associated with electrode315 u is positioned opposite across the electrically conductive surfacefrom the first electrode edge 333 a. In this particular embodiment, thesecond electrode edge 333 b is arranged to follow a portion of one ofthe side edges 327 of the second elongate member 304 b (e.g., side edge327 a of second elongate member 304 b). In this particular embodiment,the second electrode edge 333 b is substantially parallel to the sideedge 327 a of second elongate member 304 b.

FIGS. 3F and 3G respectively show perspective and plan views of aplurality of transducers and electrodes located on a structure 313(e.g., in a deployed configuration) according to various embodiments. Invarious embodiments, structure 313 is selectively moveable from adelivery configuration to a deployed configuration in a manner similarto structure 308. It is noted that structure 313 is depicted in FIGS. 3Fand 3G in a similar fashion to depictions of structure 308 in FIGS. 3Cand 3D. In some embodiments, distributions of transducers or electrodessimilar to those employed by structure 313 are employed by the structure308 of FIGS. 3A, 3B, 3C, 3D and 3E. For the convenience of discussion,various elements associated with structure 313 will be identified by therespective part numbers of the corresponding elements associated withstructure 308. For example, in reference to FIGS. 3F and 3G and otherassociated Figures, transducers are referred to as transducers 306,electrodes are referred to as electrodes 315, energy transmissionsurfaces are referred to as energy transmission surfaces 319, elongatemembers are referred to as elongate members 304, et cetera. It is notedthat these elements disclosed in FIGS. 3F and 3G and other associatedFigures are not limited to the embodiments of corresponding elementsdisclosed in FIGS. 3A, 3B, 3C, 3D and 3E. In some embodiments, structure313 may assume a delivery configuration similar to that shown forstructure 308 in FIG. 3A.

It may be noted that although the distributions of transducers306/electrodes 315 associated with structure 313 have differences fromthe distribution of transducers 306/electrodes 315 associated withstructure 308, there are also similarities. The respective intermediateportions 309 of various ones of the elongate members 304 (five calledout in each of FIGS. 3F and 3G, four of the five called out as 304 d,304 e, 304 f and 304 g) are angularly spaced with respect to one anotherabout a first axis 335 b when structure 313 is in the deployedconfiguration in a manner similar to that previously described withrespect to structure 308. Various ones of the elongate members 304 crossone another at a location on the structure 313 passed through by firstaxis 335 b when the structure 313 is in the deployed configuration. Inat least one particular embodiment associated with FIGS. 3F, 3G, theintermediate portion 309 of a first elongate member (e.g., elongatemember 304 d) overlaps the intermediate portion 309 of a second elongatemember (e.g., elongate member 304 e) at a location on structure 313passed through by first axis 335 b when structure 313 is in the deployedconfiguration. In at least one particular embodiment associated withFIGS. 3F, 3G, the intermediate portion 309 of first elongate member 304d is adjacent the intermediate portion 309 of the second elongate member304 e when structure 313 is in the deployed configuration. Thetransducers 306 (nine called out in each of FIGS. 3F and 3G, eight ofthe nine called as transducers 306 w, 306 x, 306 y, 306 z, 306 aa, 306bb, 306 cc, and 306 dd) and electrodes 315 (nine called out in each ofFIGS. 3F and 3G, eight of the nine called out as electrodes 315 w, 315x, 315 y, 315 z, 315 aa, 315 bb, 315 cc and 315 dd) are radially spacedabout first axis 335 b when structure 313 is in the deployedconfiguration in a manner similar to the embodiments associated withstructure 308. The plurality of electrodes 315 located on structure 313includes a first group 336 b (not called out in FIGS. 3H, 3I) of theelectrodes 315 located on first elongate member 304 d and a second group338 c (not called out in FIGS. 3H, 3I) of the electrodes 315 located onsecond elongate member 304 e. It is understood that although electrodesare herein described, other forms of transducers or transducer elementsmay be employed in other embodiments. The electrodes 315 of the firstgroup 336 b are arranged such that each electrode 315 of the first group336 b is intersected by a first plane 342 b having no thickness. Theelectrodes 315 of the second group 338 c are arranged such that eachelectrode 315 of the second group 338 c is intersected by a second plane344 c having no thickness. For clarity, the intersection of eachelectrode 315 of the first group 336 b by first plane 342 b isrepresented in FIG. 3F by intersection line 345 c. For clarity, theintersection of each electrode 315 of the second group 338 c by secondplane 344 c is represented in FIG. 3F by intersection line 345 d. Firstplane 342 b and second plane 344 c are depicted as having boundaries forclarity of illustration in FIG. 3F.

Each of the first plane 342 b and the second plane 344 c arenon-parallel planes that intersect each other along a second axis 337 c(represented by a symbol “•” in FIG. 3G). In some embodiments, secondaxis 337 c is parallel to first axis 335 b. In some embodiments, firstaxis 335 b and second axis 337 c are collinear. In some embodiments, thefirst axis 335 b and the second axis 337 c form a single axis. In someembodiments, the electrodes 315 are arranged in a spatial distributionin which a first electrode 315 (e.g., electrode 315 w associated withtransducer 306 w) is intersected by each of the first plane 342 b andthe second plane 344 c when the structure 313 is in the deployedconfiguration. In at least one particular embodiment, first electrode315 w is not intersected by first axis 335 b when structure 313 is inthe deployed configuration. In at least one particular embodiment, firstelectrode 315 w is not intersected by second axis 337 c when structure313 is in the deployed configuration. In at least one particularembodiment, the first group 336 b of electrodes 315 includes firstelectrode 315 w. In at least one particular embodiment, the second groupof electrodes 338 c does not include first electrode 315 w. In variousembodiments, the first axis 335 a, the second axis 337 c or each of thefirst axis 335 and the second axis 337 c intersects at least one otherelectrode 315 located on structure 313 (e.g., electrode 315 x associatedwith transducer 306 x in FIGS. 3F, 3G and 3I). In some embodiments, thefirst axis 335 b, the second axis 337 c or each of the first axis 335 band the second axis 337 c do not intersect any electrode 315 located onstructure 313.

In some embodiments, the second axis 337 c is not collinear with thefirst axis 335 b. In some embodiments, the second axis 337 c and thefirst axis 335 b do not form a single axis. In some embodiments, thesecond axis 337 c does not intersect the first axis 335 b. FIG. 3G showsanother embodiment in which each electrode 315 of second group 338 d(not called out in FIGS. 3F, 3H and 3I) of electrodes 315 located on asecond elongate member 304 f is intersected by a second plane 344 dhaving no thickness when structure 313 is in a deployed configuration.Second plane 344 d is viewed transversely to its planar surface in FIG.3G and is represented by a line. For clarity, second plane 344 d is notshown in FIG. 3F. First plane 342 b and second plane 344 d are nonparallel planes that intersect one another along a second axis 337 drepresented by a symbol “•” in FIG. 3G. In at least one particularembodiment, each of the first plane 342 b and the second plane 344 dintersects a first electrode 315 y associated with transducer 306 y whenstructure 313 is in a deployed configuration. In at least one particularembodiment, first electrode 315 y is not intersected by the first axis335 b when structure 313 is in a deployed configuration. In at least oneparticular embodiment, first electrode 315 y is not intersected by thesecond axis 337 d when structure 313 is in a deployed configuration. Inat least one particular embodiment, second axis 337 d intersects atleast one other electrode (e.g., electrode 315 z associated withtransducer 306 z) when structure 313 is in a deployed configuration.

Embodiments associated with FIGS. 3F and 3G have spatial distributionsof the transducers 306/electrodes 315 that have relatively high spatialdensities in various regions of structure 313 including a plurality ofregions proximate first axis 335 b. In various embodiments, a spatialdistribution of the transducers 306/electrodes 315 in various regionsproximate first axis 335 b have higher spatial densities than similardistributions associated with various embodiments of FIGS. 3A, 3B, 3C,3D and 3E. Embodiments associated with FIGS. 3F and 3G may provide forelectrodes 315 having electrically conductive surfaces (e.g., energytransmission surfaces 319, three called out in each of FIGS. 3F and 3G,two of the three called out as 319 c and 319 d) of greater size ordimension than some of the electrodes 315 associated with variousembodiments of FIGS. 3A, 3B, 3C, 3D and 3E. In particular, largerelectrodes 315 may be provided in regions proximate first axis 335 b inat least some of the embodiments associated with FIGS. 3F and 3G. Theuse of larger electrodes (e.g., larger electrically conductive surfacessuch as energy transmission surfaces 319 c and 319 d) may be motivatedfor various reasons. For example, in some tissue ablation applications,tissue ablation depths may be dependent on the size of the electrodes315 employed for the ablation, with a use of larger electrodes 315typically reaching a particular ablation depth in a shorter activationtime than a use of relatively smaller electrodes 315. In some tissueablation applications, deeper tissue ablation depths may be associatedwith larger electrodes.

FIG. 3H is shows perspective views of each of first elongate member 304d and second elongate member 304 e in a “flattened” configuration inwhich the curved form of these elongate members 304 in FIGS. 3F and 3Gis flattened out. It is noted that in embodiments where the elongatemembers 304 in FIGS. 3F and 3G include a twisted portion similar to thetwisted portions of various ones of the elongate members 304 associatedwith FIGS. 3A, 3B, 3C, 3D and 3E, the twisted portions are shownuntwisted in the flattened configuration of FIG. 3H. The flattenedconfiguration is presented for clarity of illustration and it isunderstood that in the deployed configuration, FIGS. 3F and 3G arebetter representative of the forms of various ones of the elongatemembers at least in the deployed configuration. In a manner similar tothe elongate members 304 of structure 308, the intermediate portion 309of each of the elongate members 304 d, 304 e includes a front surface318 a and back surface 318 b opposite across a thickness 318 c of theelongate member. In some embodiments, at least some of the transducers306/electrodes 315 are located on the front surfaces 318 a. Eachintermediate portion 309 includes a respective pair of side edges 327 a,327 b. In various embodiments, the side edges 327 a, 327 b of eachintermediate portion 309 are respective side edges of the front surface318 a, the back surface 318 b, or both the front surface 318 a and theback surface 318 b of the intermediate portion 309. Each of the pair ofside edges 327 a, 327 b extends between the proximal end 307 and thedistal end 305 of the elongate member 304.

In some embodiments associated with FIGS. 3F and 3G, various ones ofelongate members overlap one another when structure 313 is in thedeployed configuration. In various embodiments, overlapping elongatemembers 304 may be employed at least in part to provide to distributionsof the electrodes 315 having higher spatial densities. FIG. 3I includesan enlarged view of a portion of the structure 313 depicted in FIG. 3G,the portion of structure 313 including portions of at least elongatemembers 304 d and 304 e. For clarity of illustration, planes 342 b, 344c, 344 d and axis 337 d are not shown in FIG. 3I.

In at least one particular embodiment, various portions of the frontsurface 318 a of the first elongate member 304 d overlap variousportions of the front surface 318 a of each of several ones of theplurality of elongate members 304 when structure 313 is in the deployedconfiguration. In at least one particular embodiment, various portionsof the front surface 318 a of the first elongate member 304 d overlapvarious portions of the front surface 318 a of every other one of theplurality of elongate members 304 when structure 313 is in the deployedconfiguration. In at least one particular embodiment associated withFIG. 3I, a portion 346 c (i.e., only called out in FIG. 3I) of the frontsurface of 318 a of a first elongate member 304 (e.g., elongate member304 d) overlaps a portion 347 c (i.e., only called out in FIG. 3I,partially bounded by a ghosted line 345 c) of the front surface 318 a ofat least a second elongate member (e.g., elongate member 304 e) asviewed normally to the portion 346 a of the front surface 318 a of firstelongate member 304 a when structure 313 is in the deployedconfiguration. In at least one particular embodiment, the spatialdensity of the distribution of transducers 306/electrodes 315 is suchthat at least a first electrode (e.g., first electrode 315 w associatedwith transducer 306 w) is located at least on the portion 346 c of thefront surface 318 a of first elongate member 304 d. In at least oneparticular embodiment, the portion of 347 c of the front surface 318 aof second elongate member 304 e faces the back surface 318 b (not calledout in FIG. 3I) of first elongate member 304 d when structure 313 is inthe deployed configuration. In some embodiments, the portion of 347 c ofthe front surface 318 a of second elongate member 304 e faces the backsurface 318 b of first elongate member 304 d when structure 313 is inthe delivery configuration (e.g., when the elongate members 304 arearranged front surface-toward-back surface in a stacked array when thestructure 313 is in a delivery configuration similar to that depicted inFIG. 3A). In some example embodiments, the portion of 347 c of the frontsurface 318 a of second elongate member 304 e contacts the back surface318 b of first elongate member 304 d when structure 313 is in thedeployed configuration.

In FIGS. 3F, 3G and 3I, the first elongate member 304 d is positionedsuch that first edge 327 a of the first elongate member 304 d crosses atleast a second edge of the second elongate member 304 e (e.g., secondedge 327 b of second elongate member 304 e) when structure 313 is in thedeployed configuration. In some of the embodiments associated with FIGS.3F, 3G, 3H and 3I a portion of the first edge 327 a of the firstelongate member 304 d forms a recessed portion 328 a of first elongatemember 304 d that exposes at least a portion of a second transducer 306aa (e.g., second electrode 315 aa in at least one particular embodiment)located on second elongate member 304 e. All recessed portions such asrecessed portion 328 a described herein are collectively referred to asrecessed portions 328. In at least some of the embodiments associatedwith FIGS. 3F, 3G, 3H and 3I, the exposed portion of second transducer306 aa (e.g., electrode 315 aa) is located at least on portion of asurface (e.g., front surface 318 a) of the second elongate member 304 eas viewed normally to the portion of the surface of the second elongatemember 304 e when structure 313 is in the deployed configuration. In atleast some of the embodiments associated with FIGS. 3F, 3G, 3H and 3I,recessed portion 328 a of first elongate member 304 d exposes at least aportion of second electrode 315 aa as viewed normally to a surface ofthe exposed portion of second electrode 315 aa. In at least some of theexample embodiments associated with FIGS. 3F, 3G, 3H and 3I, the exposedportion of second transducer 306 aa (e.g., electrode 315 aa) is locatedon the second elongate member 304 e as viewed towards the secondtransducer 306 aa along a direction parallel to a direction that thefirst axis 335 b extends along when structure 313 is in the deployedconfiguration. In some embodiments, the second group 338 c includessecond transducer 306 aa (e.g., electrode 315 aa). As best shown inFIGS. 3G and 3I, in some embodiments, the second transducer 306 aa(e.g., electrode 315 aa) is adjacent first transducer 306 w (e.g.,electrode 315 w) when structure 313 is in the deployed configuration. Invarious embodiments associated with FIGS. 3F, 3G, 3H and 3I, at leastsome of the plurality of transducers 306/electrodes 315 are arranged ina plurality of concentric ringed arrangements 329 (four called out inFIG. 3G (one of which is shown by a ghosted line), two of the fourcalled out as 329 a, 329 b) about the first axis 335 b when structure313 is in the deployed configuration, a first one of the ringedarrangements 329 (e.g., ringed arrangement 329 a) having a fewer numberof the transducers 306 (e.g., electrodes 315) than a second one of theringed arrangements (e.g., ringed arrangement 329 b). In some of thesevarious example embodiments, the first ringed arrangement includes firsttransducer 306 w (e.g., electrode 315 w). In some of these variousembodiments, the first ringed arrangement 329 a does not include any ofthe transducers 306 (e.g., electrodes 315) located on the secondelongate member 304 e. In some of these example embodiments, the secondringed arrangement 329 b includes the second transducer 306 aa. In someof these various embodiments, the first ringed arrangement 329 a isadjacent the second ringed arrangement 329 b.

In various embodiments, first elongate member 304 d includes a secondrecessed portion 328 b (called out in FIGS. 3F, 3G and 3H) arranged toexpose a portion of at least one transducer (e.g., electrode 315 bbassociated with transducer 306 bb) located on second elongate member 304e when structure 313 is in the deployed configuration. In variousembodiments, second elongate member 304 e includes several recessedportions (e.g., recessed portions 328 c and 328 d called out in FIGS.3H, 3J. In at least one particular embodiment, each of the recessedportions 328 c and 328 d has different dimensions or sizes than each ofrecessed portions 328 a and 328 b. Differences in the dimensions orsizes of various ones of the recessed portions 328 (e.g., any ofrecessed portions 328 a, 328 b, 328 c, 328 d and other describedrecessed portions) may be motivated by various reasons including thelocation of their corresponding elongate member 304 in structure 313 ora spatial relationship between various ones of the transducers306/electrodes 315 in the deployed configuration. In some embodiments,the differences in the sizes or dimensions of various ones of therecessed portions 328 may be employed to create distribution oftransducers 306/electrodes 315 having higher spatial densities. Invarious embodiments, each recessed portion 328 c, 328 d is arranged toexpose a portion of at least one transducer 306 (e.g., electrode 315 ccassociated with transducer 306 cc and electrode 315 dd associated withtransducer 306 dd) located on elongate member 304 g when structure 313is in the deployed configuration. This is best shown in FIG. 3J whichshows a plan view of structure 313 in the deployed configuration similarto that shown in FIG. 3G with the exception that elongate member 304 dis not shown. It is understood that elongate member 304 d is not shownin FIG. 3J only to better show elongate member 304 e and its associatedrecessed portions 328 c and 328 d. For clarity of illustration, planes342 b, 344 c, 344 d and axes 335 b, 337 c, 337 d are not shown in FIG.3J.

In various embodiments associated with FIG. 3J, a first side edge 327 aof a first elongate member (e.g., elongate member 304 e) crosses a firstside edge 327 a of the pair of side edges of a second elongate member(e.g., elongate member 304 g) at a first location 351 b and crosses asecond side edge 327 b of the pair of side edges of the second elongatemember 304 g at a second location 352 b when structure 313 is in thedeployed configuration. In various embodiments associated with FIG. 3J,various electrodes 315 are located at least on a portion 348 b of thesecond elongate member 304 g, the portion 348 b of the second elongatemember 304 g located between a first transverse line 349 c and a secondtransverse line 349 d (e.g., each depicted by a ghosted line in FIG. 3J)when the structure 313 is in the deployed configuration. In variousembodiments associated with FIG. 3J, the first transverse line 349 cextends across a first width 353 c of the second elongate member 304 gat the first location 351 b and the second transverse line 349 d extendsacross a second width 353 d of the second elongate member 304 g at thesecond location 352 b. In at least one particular embodiment associatedwith FIG. 3J, the first width 353 c and the second width 353 d are thewidths of the front surfaces 318 a of the second elongate member 304 g.In at least one particular embodiment associated with FIG. 3J, amagnitude of first width 353 c is substantially the same as a magnitudeof the second width 353 d. In some embodiments, a magnitude of the firstwidth 353 c is different than a magnitude of the second width 353 d. Inat least one particular embodiment associated with FIG. 3J, each ofelectrodes 315 cc associated with transducer 306 cc and electrode 315 ddassociated with transducer 306 dd is wholly located on the portion 348 bof the second elongate member 304 g when the structure 313 is in thedeployed configuration. In at least one particular embodiment associatedwith FIG. 3J, electrode 315 ee associated with transducer 306 ee islocated at least on portion 348 b in the deployed configuration. Similararrangements exist between other sets of the elongate members 304 ofstructure 313 in the deployed configuration. For example, referring toFIG. 3I, a first elongate member (e.g., elongate member 304 d) ispositioned such that its first edge 327 a crosses a first side edge 327a of a second elongate member (elongate member 304 e) at a firstlocation 351 c and crosses a second side edge 327 b of the secondelongate member 304 e at a second location 352 c when the structure 313is in the deployed configuration. Electrode 306 aa associated withtransducer 306 aa is wholly located on a portion 348 c of the secondelongate member 304 e, the portion 348 c located between a firsttransverse line 349 e and a second transverse line 349 f when thestructure 313 is in the deployed configuration. The first transverseline 349 e extends across a first width 353 e of the second elongatemember 304 e at the first location 351 c, and the second transverse line349 f extends across a second width 353 f of the second elongate member304 e at the second location 352 c. In this particular embodiment, thefirst width 353 e is smaller than the second width 353 f.

In a manner similar to embodiments associated with FIGS. 3A, 3B, 3C, 3Dand 3E, electrically conductive surfaces (e.g., energy transmissionsurfaces 319) of various ones of the electrodes 315 employed in variousembodiments associated with FIGS. 3F, 3G, 3H, 3I, and 3J may havedifferent sizes or shapes. For example, referring to FIG. 3J, it isnoted that each of various one of the electrodes 315 (e.g., electrodes315 cc, 315 dd and 315 ee) located on at least on elongate member 304 ghave different shapes and sizes. In at least one particular embodimentassociated with FIG. 3J, a periphery of an electrically conductivesurface (e.g., an energy transmission surface 319) of various ones ofthe electrodes 315 is defined by various electrode edges. For example,electrode 315 dd includes a first electrode edge 333 c and a secondelectrode edge 333 d opposite across an electrically conductive surfaceof electrode 315 dd from the first electrode edge 333 c. In at least oneparticular embodiment, the first electrode edge 333 c associated withelectrode 315 dd is arranged to follow a portion of the first side edge327 a of the overlapping elongate member 304 e between the firstlocation 351 b and the second location 352 b when the structure 313 isin an expanded or deployed configuration. In at least one particularembodiment, the first electrode edge 333 c of electrode 315 dd isarranged to be parallel to the portion of the first side edge 327 a ofthe overlapping elongate member 304 e between the first location 351 band the second location 352 b when the structure 313 is in an expandedor deployed configuration. In at least one particular embodiment, thefirst electrode edge 333 c of electrode 315 dd is arranged to follow aportion of the first side edge 327 a that defines or forms part of, therecessed portion 328 c of overlapping elongate member 304 e in theexpanded or deployed configuration. In at least one particularembodiment, the second electrode edge 333 d associated with electrode315 dd is arranged to follow a portion of one of the side edges 327 ofelongate member 304 g (e.g., side edge 327 a of second elongate member304 g). In at least one particular embodiment, the second electrode edge333 d associated with electrode 315 dd is arranged to follow a portionof one of the side edges 327 of elongate member 304 g (e.g., side edge327 a of second elongate member 304 g) that defines, or forms part of, arecessed portion 328 j of the elongate member 304 g. In at least oneparticular embodiment, a first part of a first electrode edge 333 eassociated with electrode 315 ee located on elongate member 304 g isarranged to follow a portion of the first side edge 327 a that defines,or forms part of, the recessed portion 328 c of overlapping elongatemember 304 e when structure 313 is in the deployed configuration, and asecond part of the first electrode edge 333 e of electrode 315 ee isarranged to follow a portion of the first side edge 327 a that does notdefine or form part of the recessed portion 328 c of overlappingelongate member 304 e when structure 313 is in an expanded or deployedconfiguration. In at least one particular embodiment, a first part of asecond electrode edge 333 f associated with electrode 315 ee is arrangedto follow a portion of the first side edge 327 a that defines, or formspart of, the recessed portion 328 j of the elongate member 304 g, and asecond part of the second electrode edge 333 f is arranged to follow aportion of the first side edge 327 a of elongate member 304 j that doesnot define, or form part of, the recessed portion 328 j.

In at least one particular embodiment associated with FIGS. 3F, 3G, 3H,and 3I, the edge 327 a of the first elongate member 304 d is interruptedby a notch 330 a. Similarly, in some embodiments, the edge 327 a of thefirst elongate member 304 d is interrupted by recessed portion 328 a ofthe first elongate member 304 d. In some embodiments, the recessedportion 328 a forms at least a portion of the notch 330 a. In thisparticular illustrated embodiment, notch 330 a is located in theintermediate portion 309 of the first elongate member 304 d and extendstowards the second edge 327 b. In a similar fashion, the recessedportions 328 b, 328 c and 328 d may form a portion of a respective oneof notches 330 b, 330 c and 330 d (called out in FIG. 3H) in variousembodiments. In various embodiments associated with FIGS. 3F, 3G, 3H, 3Iand 3J, various ones of the recessed portions 328 may be advantageouslyemployed to create, at least in part, a spatial distribution of thetransducers 315 having a relatively high spatial density. In variousembodiments associated with FIGS. 3F, 3G, 3H, 3I and 3J, various ones ofrecessed portions 328 may be advantageously employed to address, atleast in part, transducer size or shape constraints associated withstructure 313 (e.g., overlapping regions of elongate members 304 orvarying distances between various elongate members 304). In variousembodiments associated with FIGS. 3F, 3G, 3H, 3I and 3J, various ones ofrecessed portions 328 may allow, at least in part, for the use ofelectrodes 315 having relatively large electrically conductive surfaces(e.g., energy transmission surfaces 319). Other benefits may accompanythe use of recessed portions such as recessed portions 328. For example,in some embodiments, recessed portions similar to various ones of recessportions 328 may be employed to increase fluid flow (e.g., blood flow)in a particular region of structure 313 (e.g., a region where elongatemembers 304 overlap one another) that may hinder or otherwise obstruct aflow of fluid (e.g., blood flow).

In other embodiments, various ones of the recessed portions 328 may takea form other than a notch (e.g., notch 330 a). For example, FIG. 3Kincludes a perspective view of two elongate members 304 h and 304 i in aflattened configuration similar to that shown by elongate members 304 dand 304 e in FIG. 3H. Elongate members 304 h and 304 i are similar toelongate members 304 d and 304 e in various embodiments, form part ofstructure of a transducer-based device system (not shown) similar tostructures 308, 313. In some of these various embodiments, the structuremay be configurable between a delivery configuration and a deployedconfiguration similar to that previously described in this detaileddescription. In some of these various embodiments, elongate member 304 hoverlaps elongate member 304 i when the structure is the deployedconfiguration in a manner similar to elongate members 304 d and 304 e.For convenience of discussion, various elements of each of elongatemembers 304 h and 304 i are identified by the same part numbers employedto identify similar elements in other previously described elongatemembers. In some embodiments, each of elongate members 304 h and 304 iincludes an intermediate portion 309 that includes a front surface 318 aand back surface 318 b opposite across a thickness 318 c of the elongatemember. In some embodiments, at least some of the transducers306/electrodes 315 are located on the front surfaces 318 a. Eachintermediate portion 309 includes a respective pair of side edges 327 a,327 b extending between proximal and distal ends 307, 305 of theelongate member 304. In a manner similar to that shown in FIGS. 3F, 3G,and 3I the first elongate member 304 h may be positioned such that firstedge 327 a of the first elongate member 304 h crosses a second edge 327b of the second elongate member 304 i when the associated structure isin the deployed configuration. In a manner similar to elongate members304 d, 304 e, each of the elongate members 304 h, 304 i includes a setof recessed portions 328 (e.g., associated ones of recessed portions 328e, 328 f, 328 g, 328 h). In some embodiments, each of the elongatemembers 304 h, 304 i includes a jogged portion (e.g., a respective oneof jogged portions 331 a, 331 b), each jogged portion undergoing atleast one change in direction as the jogged portion extends between theproximal and distal ends 307, 305 of the respective elongate member. Invarious embodiments, various ones of the recessed portions 328 e, 328 f,328 g and 328 h may form a part of one of the jogged portions 331 a, 331b. In various embodiments, various ones of the recessed portions 328 e,328 f, 328 g and 328 h may be located on respective ones of the elongatemembers 304 h and 304 i to expose a portion of at least one transducer306/electrode 315 located on another elongate member 304 (e.g., when anassociated structure that includes the elongate members 304 is in adeployed configuration). In other example embodiments, a surface of aparticular one of the elongate members may be interrupted by a channel(e.g., trough, groove, aperture), the channel located to expose aportion of at least one transducer 306/electrode 315 located on anotherelongate member 304 especially when an associated structure thatincludes the elongate members 304 is in a deployed configuration.

While some of the embodiments disclosed above are described withexamples of cardiac mapping, the same or similar embodiments may be usedfor mapping other bodily organs, for example gastric mapping, bladdermapping, arterial mapping and mapping of any lumen or cavity into whichthe devices of the present invention may be introduced.

While some of the embodiments disclosed above are described withexamples of cardiac ablation, the same or similar embodiments may beused for ablating other bodily organs or any lumen or cavity into whichthe devices of the present invention may be introduced.

Subsets or combinations of various embodiments described above canprovide further embodiments.

These and other changes can be made to the invention in light of theabove-detailed description. In general, in the following claims, theterms used should not be construed to limit the invention to thespecific embodiments disclosed in the specification and the claims, butshould be construed to include other transducer-based device systemsincluding all medical treatment device systems and medical diagnosticdevice systems in accordance with the claims. Accordingly, the inventionis not limited by the disclosure, but instead its scope is to bedetermined entirely by the following claims.

What is claimed is:
 1. A medical device system comprising: a structure;and a plurality of electrodes positionable in a bodily cavity andsupported by the structure, wherein the structure is selectivelymoveable between: a delivery configuration in which the structure issized to be percutaneously deliverable to the bodily cavity, and adeployed configuration in which the structure is sized too large to bepercutaneously deliverable to the bodily cavity, and wherein at leastsome of the plurality of electrodes are arranged in a plurality ofconcentric ringed arrangements about an axis of the structure when thestructure is in the deployed configuration, wherein a first concentricringed arrangement of the plurality of concentric ringed arrangementscomprises a first electrode that is wider in a circumferential directionof the first concentric ringed arrangement than a second electrode in asecond concentric ringed arrangement of the plurality of concentricringed arrangements, the first concentric ringed arrangement having afewer number of electrodes than the second concentric ringedarrangement, and wherein the first concentric ringed arrangement ispositioned radially inward from the second concentric ringed arrangementas viewed along the axis when the structure is in the deployedconfiguration.
 2. The medical device system of claim 1, wherein, whenthe structure is in the deployed configuration, the axis extendsoutwardly from a particular location interior the structure toward aregion of space outside the structure, and wherein, when the structureis in the deployed configuration, the first concentric ringedarrangement is positioned outwardly farther from the particular locationtoward the region of space than the second concentric ringedarrangement.
 3. The medical device system of claim 1, wherein, when thestructure is in the deployed configuration, each electrode in the firstconcentric ringed arrangement is intersected by a first plane, and eachelectrode in the second concentric ringed arrangement is intersected bya second plane.
 4. The medical device system of claim 3, wherein, whenthe structure is in the deployed configuration, the first plane isspaced from the second plane along the axis.
 5. The medical devicesystem of claim 3, wherein, when the structure is in the deployedconfiguration, the axis extends outwardly from a particular locationinterior the structure toward a region of space outside the structure,and wherein, when the structure is in the deployed configuration, thefirst plane is positioned outwardly farther from the particular locationtoward the region of space than the second plane.
 6. The medical devicesystem of claim 1, wherein the first electrode in the first concentricringed arrangement has a different shape than a shape of the secondelectrode in the second concentric ringed arrangement.
 7. The medicaldevice system of claim 6, wherein a shape of at least one electrode inthe first concentric ringed arrangement tapers toward the axis when thestructure is in the deployed configuration.
 8. The medical device systemof claim 6, wherein the shape of the second electrode tapers toward theaxis when the structure is in the deployed configuration.
 9. The medicaldevice system of claim 1, wherein the structure comprises a plurality ofelongate members, each elongate member comprising an elongated portionarranged to extend toward the axis when the structure is in the deployedconfiguration, and wherein each respective electrode of a group ofelectrodes from the plurality of electrodes is located on a respectiveone of the plurality of elongate members.
 10. The medical device systemof claim 9, wherein multiple electrodes from the plurality of electrodesare located on each of a set of one or more elongate members of theplurality of elongate members.
 11. The medical device system of claim10, wherein each of the elongated portions of the plurality of elongatemembers is arranged to extend along a respective curved path toward theaxis when the structure is in the deployed configuration.
 12. Themedical device system of claim 11, wherein each respective curved pathis convex facing outwardly away from the axis when the structure is inthe deployed configuration.
 13. The medical device system of claim 9,wherein each respective elongate member of the plurality of elongatemembers comprises a flexible circuit structure including an electricallyinsulative flexible layer and a patterned electrically conductive layersupported by the electrically insulative flexible layer, the patternedelectrically conductive layer in electrical communication with therespective electrode of the group of electrodes from the plurality ofelectrodes to selectively deliver electrical energy thereto.
 14. Themedical device system of claim 13, wherein the electrical energy issufficient to ablate tissue.
 15. The medical device system of claim 9,wherein the elongated portions of the plurality of elongate members arearranged to meet at the axis when the structure is in the deployedconfiguration.
 16. The medical device system of claim 15, wherein eachrespective elongate member of the plurality of elongate memberscomprises a flexible circuit structure including an electricallyinsulative flexible layer and a patterned electrically conductive layersupported by the electrically insulative flexible layer, the patternedelectrically conductive layer in electrical communication with therespective electrode of the group of electrodes from the plurality ofelectrodes to selectively deliver electrical energy thereto.
 17. Themedical device system of claim 16, wherein the electrical energy issufficient to ablate tissue.
 18. The medical device system of claim 9,wherein the elongated portions of the plurality of elongate members arearranged to extend like lines of longitude toward the axis when thestructure is in the deployed configuration.
 19. The medical devicesystem of claim 18, wherein each respective elongate member of theplurality of elongate members comprises a flexible circuit structureincluding an electrically insulative flexible layer and a patternedelectrically conductive layer supported by the electrically insulativeflexible layer, the patterned electrically conductive layer inelectrical communication with the respective electrode of the group ofelectrodes from the plurality of electrodes to selectively deliverelectrical energy thereto.
 20. The medical device system of claim 19,wherein the electrical energy is sufficient to ablate tissue.
 21. Themedical device system of claim 9, wherein the plurality of elongatemembers includes a first elongate member and a second elongate member,wherein each of at least the first electrode in the first concentricringed arrangement and the second electrode in the second concentricringed arrangement is located on the first elongate member, and whereinthe first concentric ringed arrangement does not include any electrodelocated on the second elongate member.
 22. The medical device system ofclaim 21, wherein the second concentric ringed arrangement includes athird electrode located on the second elongate member.
 23. The medicaldevice system of claim 22, wherein the second electrode and the thirdelectrode are circumferentially adjacent in the second concentric ringedarrangement.
 24. The medical device system of claim 22, wherein theplurality of elongate members comprises a third elongate member, whereineach of at least a fourth electrode in the first concentric ringedarrangement and a fifth electrode in the second concentric ringedarrangement is located on the third elongate member.
 25. The medicaldevice system of claim 24, wherein at least the elongated portion of thesecond elongate member is located between at least the respectiveelongated portions of the first elongate member and the third elongatemember when the structure is in the deployed configuration.
 26. Themedical device system of claim 24, wherein at least the elongatedportion of the first elongate member and at least the elongated portionof the second elongate member are adjacent when the structure is in thedeployed configuration, and wherein at least the elongated portion ofthe second elongate member and at least the elongated portion of thethird elongate member are adjacent when the structure is in the deployedconfiguration.
 27. The medical device system of claim 24, wherein atleast the elongated portions of the plurality of elongate members arecircumferentially arranged about the axis when the structure is in thedeployed configuration, and wherein at least the elongated portion ofthe second elongate member is circumferentially between at least theelongated portion of the first elongate member and at least theelongated portion of the third elongate member when the structure is inthe deployed configuration.
 28. The medical device system of claim 27,wherein at least a particular portion of the second elongate member islocated between the first electrode and the fourth electrode when thestructure is in the deployed configuration.
 29. The medical devicesystem of claim 27, wherein the second electrode, the third electrode,and the fifth electrode are provided by two pairs of circumferentiallyadjacent electrodes in the second concentric ringed arrangement.
 30. Themedical device system of claim 24, wherein the first electrode and thefourth electrode are circumferentially adjacent electrodes in the firstconcentric ringed arrangement.
 31. The medical device system of claim21, wherein each respective elongate member of the plurality of elongatemembers comprises a flexible circuit structure including an electricallyinsulative flexible layer and a patterned electrically conductive layersupported by the electrically insulative flexible layer, the patternedelectrically conductive layer in electrical communication with therespective electrode of the group of electrodes from the plurality ofelectrodes to selectively deliver electrical energy thereto.
 32. Themedical device system of claim 31, wherein the electrical energy issufficient to ablate tissue.
 33. The medical device system of claim 1,wherein the structure comprises a plurality of elongate members, eachelongate member of the plurality of elongate members comprising anelongated portion arranged to extend toward the axis when the structureis in the deployed configuration, a respective group of electrodes fromthe plurality of electrodes located on a respective elongate member ofat least some of the plurality of elongate members; and each respectiveelongate member of the at least some of the plurality of elongatemembers comprises a flexible circuit structure including an electricallyinsulative flexible layer and a patterned electrically conductive layersupported by the electrically insulative flexible layer, the patternedelectrically conductive layer comprising a plurality of leads, each leadin electrical communication with a respective electrode of therespective group of electrodes from the plurality of electrodes toselectively deliver electrical energy thereto.
 34. The medical devicesystem of claim 33, wherein the electrical energy is sufficient toablate tissue.
 35. The medical device system of claim 1, wherein eachelectrode of the plurality of electrodes is selectively activatable totransmit energy sufficient to ablate tissue.
 36. The medical devicesystem of claim 1, wherein each of the first electrode and the secondelectrode is selectively activatable to transmit energy sufficient toablate tissue.
 37. A method of operating a medical device systemcomprising a structure and a plurality of electrodes positionable in abodily cavity, the plurality of electrodes supported by the structure,the method comprising: manipulating the structure between a firstconfiguration in which the structure is sized to be percutaneouslydeliverable to the bodily cavity and a second configuration in which thestructure is in a state in which at least some of the plurality ofelectrodes are arranged in a plurality of concentric ringed arrangementsabout an axis of the structure, a first concentric ringed arrangement ofthe plurality of concentric ringed arrangements comprising a firstelectrode that is wider in a circumferential direction of the firstconcentric ringed arrangement than a second electrode in a secondconcentric ringed arrangement of the plurality of concentric ringedarrangements, the first concentric ringed arrangement having a fewernumber of electrodes than the second concentric ringed arrangement, andthe first concentric ringed arrangement positioned radially inward fromthe second concentric ringed arrangement as viewed along the axis whenthe structure is in the second configuration.
 38. The method of claim37, wherein each electrode of the plurality of electrodes is selectivelyactivatable to transmit energy sufficient to ablate tissue.